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Congenital heart disease (CHD) is the most common birth defect occurring in approximately 1 in 
100 live births. A hallmark feature of children with CHD is exercise intolerance, despite successful 
surgical intervention and medical management. Although central mechanisms have been shown to 
play a role in reduced exercise tolerance in children with CHD, information regarding the influence 
of peripheral mechanisms is lacking. Exercise rehabilitation programs have been shown to improve 
exercise tolerance in children with CHD; however, exercise tolerance is still limited compared to 
healthy matched controls. Whether a home-based exercise intervention including primarily 
strength activities improves muscle oxygenation (as measured by tissue oxygenation index, TOI) 
in children with CHD compared to healthy children is unknown. PURPOSE: To determine 
whether a 12-week home-based exercise intervention can improve TOI, V̇O2 and heart rate (HR) 
during submaximal and maximal exercise in children with CHD compared to healthy children. 
METHODS: 14 children with simple and complex lesions (f/m: 5/9; mean ± SD age: 12±2 yrs) 
and nine healthy controls (f/m: 5/4; mean ± SD age: 12±3 yrs) were studied. Children with CHD 
completed a home-based exercise program 3 times/week for 12 weeks, in addition to 6 biweekly 
in-person sessions. Exercise tolerance was assessed with peak V̇O2 testing to volitional fatigue on 
a cycle ergometer. Vastus lateralis TOI was continuously sampled during the peak V̇O2 test via 
near-infrared spectroscopy (NIRS). Peak TOI, V̇O2 and HR were analyzed as the average value 
over 30-s within the last 1-minute of exercise. Submaximal TOI, V̇O2 and HR were analyzed as 
the average of the last 30-s of stage 1 (25W) and stage 2 (50W). TOI was expressed as a percentage 
scaled to the total liable signal (TLS). Pre- vs post- training changes in children with CHD were 
analyzed using paired t-tests. Pre- and post- training CHD data compared to healthy control data 
were analyzed using one-way ANOVAs with Holm-Sidak post-hoc testing. Significance was 
accepted when p < 0.05. RESULTS: TOI at peak V̇O2 was significantly lower post-training 
compared to control (20±13% vs 41±11%; p = 0.02). Peak V̇O2 was significantly lower pre-training 
(35±7 mL/kg/min vs 48±7 mL/kg/min; p = 0.006) and post-training (36±9 mL/kg/min vs 48±7 
mL/kg/min; p = 0.005) in children with CHD compared to control. Although not significant, HR 
at peak V̇O2 was lower pre- training (175±23 bpm vs 189±12 bpm; p = 0.06) and post-training 
(169±21 bpm vs 189±12 bpm; p = 0.06) in children with CHD compared to control. 
CONCLUSION: Despite no change in V̇O2 and HR, TOI is lower during submaximal and 
iii 
maximal exercise after home-based exercise in children with CHD compared to healthy children. 
Our findings suggest that peripheral mechanisms (such as oxygen uptake and utilization) can be 
improved using a strength-based exercise intervention, and may influence exercise intolerance in 
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CHAPTER ONE: LITERATURE REVIEW 
1.1 Introduction  
Congenital heart disease (CHD) is the most common birth defect occurring in 
approximately 1 in 100 live births (62), with as many as 1 in 45 children and 1 in 170 adults 
currently living with CHD in North America (33, 48). CHD lesion types range in severity based on 
size and location, and may predispose individuals to various chronic risk factors such as obesity 
and vascular disease later in life (27). Improvements in detection, management and treatment of 
CHD has resulted in an increasing number of children with CHD reaching adulthood (3, 31). 
Approximately 90% of children with CHD have the prospect of surviving to adulthood, compared 
to a survival rate of  20% 60 years ago, resulting in a growing population of adults that require life-
long cardiac care (40). Individuals with CHD account for the largest percentage of birth-defect 
associated hospitalizations (14%), and the highest total healthcare cost ($6.1 billion) (2), 
representing significant resource utilization in the health care system. Unfortunately, far fewer 
resources are allocated for adult CHD care compared to other cardiac patients, contributing to 
approximately 77% of these individuals considered lost to follow up (4). Lack of appropriate 
resources and support for adults with CHD may increase the risk of premature death (34). With a 
large disparity between adult and pediatric CHD care, it is important to address modifiable risk 
factors while in pediatric care. Children with both simple and complex CHD lesions present with 
reduced exercise tolerance when compared to healthy peers (19, 30), despite successful surgical 
intervention and appropriate medical management. Reduced exercise tolerance may predispose 
these children to cardiovascular disease later in life (1, 19, 30, 51, 58). Mechanisms that may 
contribute to persistent exercise intolerance in children with CHD are not fully understood, 
resulting in a lack of practical, evidence-based chronic disease management for these children. As 
exercise intolerance is a major predictor for all-cause and cardiovascular mortality (13, 41), further 
research in this area should be prioritized.  
 




Exercise intolerance is the single best independent predictor of mortality (13, 41). 
Individuals with CHD have been shown to have an exercise tolerance up to 60% lower than that of 
a healthy individual (30), highlighting the importance of determining mechanisms of exercise 
intolerance to improve quality of life and mitigate disease risk later in life. Central (cardiac) 
mechanisms of exercise tolerance in both adults and children with CHD have been examined 
extensively (1, 7, 49, 50, 56, 20, 22, 29, 35, 37, 38, 46, 47). CHD lesion type and severity determine 
structural and physiological abnormalities that may impair central factors such as cardiac output, 
stroke volume and left ventricular function (3), preventing the appropriate increase of oxygen (O2) 
delivery to the working muscle to match increasing metabolic demand. Chronotropic 
incompetence, or an abnormal heart rate (HR) response to exercise, is a common complication after 
surgical intervention for CHD (45), as well as a side effect from some cardiac medications. It is an 
additional central mechanism that may contribute to exercise intolerance in CHD. Chronotropic 
incompetence has been shown to be correlated with exercise tolerance and is a predictor of cardiac 
death and all-cause mortality in patients with heart failure (64). Central mechanisms contributing 
to exercise intolerance are commonly assessed objectively using a peak oxygen uptake (V̇O2) test. 
In children with CHD, previous studies have used peak V̇O2 to evaluate the effectiveness of 
structured exercise interventions in mitigating cardiac-related limitations to exercise. Rhodes et al. 
(49) demonstrated that a 12-week rehabilitation program augmented diastolic blood pressure and 
stroke volume, subsequently increasing cardiac output in children with CHD. As a result, a 
significant increase in peak V̇O2 of 4 mL/kg/min was observed post-training (49). Others have 
shown similar central adaptations to various exercise interventions, improving peak V̇O2 by 3-4 
mL/kg/min in children with CHD  (1, 20, 35, 39, 46, 49). Despite improvements in peak V̇O2 with 
exercise training, exercise tolerance in children with CHD is still reduced compared to healthy age- 
and sex-matched controls, leaving them at a higher risk for cardiovascular and all-cause mortality 
(13, 41). 
 
1.3 Peripheral mechanisms of exercise intolerance in CHD 
Peripheral (muscular and vascular) mechanisms may play a more significant role in reduced 
exercise tolerance in CHD than central mechanisms (3, 9, 10). Patients with heart failure present 
with impaired O2 delivery and utilization at the working muscle, which is a possible rate limiting 
step in reduced exercise tolerance in these individuals (5, 63). After a structured exercise training 
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intervention, adaptations at the muscle such as improved endothelial function, larger muscle fiber 
size, and increased muscle capillary and mitochondrial density have been shown (42, 63). These 
peripheral adaptations improve peak V̇O2 in patients with heart failure by increasing the amount of 
O2 that is available at the muscle and improving the efficiency of the muscle to utilize O2 for 
metabolic demands (42, 63). Individuals with heart failure may share common anatomical and/or 
physiological features with individuals with CHD that contribute to reduced exercise tolerance. 
However, few studies have provided evidence for similar peripheral limitations to exercise in adults 
and children with CHD. Many, such as Sandberg et al. (54) and Rhodes et al. (49) focus on central 
mechanisms (such as impaired cardiac output) as the primary contributor to reduced peak V̇O2, and 
only account for indirect measures of peripheral adaptations. O2 pulse is frequently used as a 
surrogate for stroke volume and O2 extraction. An increase in O2 pulse may be attributed to an 
increase in O2 extraction, leading to increased exercise tolerance in adults and children with CHD 
after an exercise intervention (7, 35, 49). Muscle strength and mass have also been used as an 
indicator of peripheral adaptation to exercise (49, 55). Augmented muscle metabolism and 
oxidative capacity are suggested to occur with increased muscle strength and mass, thereby 
enhancing O2 utilization at the muscle during exercise (49, 55). Endurance capacity may also reflect 
increased oxidative capacity and muscle capillarization in individuals with CHD (20, 54). 
Similarly, the efficiency of the muscle to pump blood back to the heart to maintain ventricular 
preload is influenced by muscle strength and mass (49, 61). Increased blood flow returning to the 
heart maintains normal increases in cardiac output during exercise; therefore, ensuring there is 
adequate O2 delivered to the muscle (49). Thus, highlighting the interplay between the central and 
peripheral mechanisms their important role in exercise tolerance. Few studies have addressed direct 
measures of peripheral mechanisms of exercise tolerance in CHD. Whether these mechanisms play 
a significant role in limiting exercise tolerance in children with CHD has yet to be determined.    
 
1.3.1 Near-infrared spectroscopy  
Microvascular function may play an important role in impaired exercise tolerance in CHD; 
however, a typical exercise tolerance test (objectively measured by peak V̇O2) cannot directly 
assess the impact of these mechanisms (17, 26, 38). Near-infrared spectroscopy (NIRS) is a 
noninvasive,  reliable and valid measurement of peripheral limitations associated with exercise 
tolerance (17, 23, 44). NIR light measures changes in oxygenated and deoxygenated hemoglobin 
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in the arterioles, capillaries and venules of the contracting muscle (6). As such, O2 delivery, 
availability and utilization in the microvasculature can be quantified using NIRS (8). Tissue 
oxygenation index (TOI) is a specific measure outputted by NIRS to assess muscle oxygenation. 
This measure has been used to evaluate microvascular dysfunction in patients with heart failure. 
Specifically, endothelial dysfunction preventing proper vasodilation during exercise, reduced 
proportion of capillaries supporting O2 delivery, as well as an impaired rate of O2 offloading from 
the blood to the working muscle (O2 flux), have been shown to contribute to exercise intolerance 
in patients with heart failure (24, 25). Following an exercise intervention, TOI is improved in heart 
failure patients as a result of augmented microvascular blood flow due to improved endothelial and 
capillary function, and muscular oxidative capacity due to an increased number of type I muscle 
fibers (21, 60).  These peripheral adaptations improve the matching of O2 delivery and utilization 
at the working muscle (18, 25, 63). To our knowledge, there are select few studies that have used 
NIRS to assess peripheral dysfunction related to exercise intolerance in CHD. In 2007, Moalla et 
al. (37) conducted a study to determine respiratory muscle function using NIRS during aerobic 
exercise in children with CHD. At exercise onset, deoxygenation (or a decrease in TOI) of the 
respiratory muscles was more pronounced in children with CHD compared to matched healthy 
controls. In addition, TOI and V̇O2 were significantly lower in children with CHD at submaximal 
and peak exercise compared to controls (37). With exercise training, improved exercise tolerance 
in children with CHD was associated with higher muscle oxygenation (increase in TOI) of the 
respiratory muscles during aerobic exercise (39). Further, similar results were found measuring 
muscle oxygenation at the vastus lateralis during isometric knee extensor exercise in children with 
CHD (36). In a subsequent study, a home-based aerobic interval training program was implemented 
(38). Post-training, enhanced muscular strength and endurance performance of the vastus lateralis 
was related to an improvement of muscle oxygenation during isometric knee extensor exercise 
(38). More recently, Sandberg et al. (53) revealed similar impaired muscle oxygenation during 
shoulder flexion exercise in adults with CHD compared to controls. They determined altered 
skeletal muscle metabolism as a contributor to reduced endurance capacity and exercise tolerance 
in adults with CHD (53). The importance of implementing rehabilitation targeting muscle function 
was also indicated to prevent further peripheral dysfunction (53). Muscle oxygenation has also 
been examined in the forearm and calf during rest (52). Adaptive responses in children with CHD 
were found to be inadequate to provide for normal muscle oxygenation at rest compared to healthy 
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peers (52). This response was attributed to reduced skeletal muscle blood flow despite maintained 
oxygen consumption, resulting in decreased O2 saturation and increased arterial-venous difference 
(52). In a focused study of children with Fontan circulation (CHD lesion type), muscle oxygenation 
was measured using NIRS at the vastus lateralis (61). Muscle oxygenation and V̇O2 were lower at 
rest and unloaded cycling compared to healthy controls, which may be related to an abnormal 
balance between O2 supply and demand in these patients, or a reduced cardiac output inherent to 
the disease (61). With varying methodology measuring muscle oxygenation in children with CHD, 
further research is needed to reduce inconsistencies and validate results. The measurement of the 
total liable signal (the difference between the baseline and nadir in TOI) should be included, to 
allow for proper calibration of the physiologic TOI range and to increase precision when comparing 
TOI values across multiple participants (43). Protocols that include measurement of muscle 
oxygenation during aerobic exercise and exercise training should be prioritized, to provide results 
that can be applied to activities of daily life and chronic disease management programming for 
children with CHD.  
 
1.4 Exercise Training in CHD  
1.4.1 Benefits of exercise training  
Structured cardiac rehabilitation programs and home-based exercise training are well 
established nonpharmacological treatments for individuals with various cardiac conditions (11). 
The positive benefits gained through regular physical activity and exercise training are extensive. 
As previously mentioned, exercise interventions have been shown to increase cardiac output, a 
central mechanism of exercise tolerance in CHD (49, 59). In addition to increases in muscle 
oxygenation, oxidative metabolism and mitochondrial and capillary density, these adaptations 
contribute to increased peak V̇O2 and exercise tolerance post-training in CHD (38, 42, 49, 55, 63).  
Peak V̇O2 is the gold standard indicator for cardiovascular and all-cause mortality risk (41). After 
an exercise intervention, peak V̇O2 has been shown to increase approximately 3-4 mL/kg/min in 
children with CHD (1, 20, 35, 39, 46, 49). This is significant as every 1 mL/kg/min gain in V̇O2 
has been shown to reduce cardiac mortality by 10% (28). Central and peripheral adaptations to 
exercise training have also been shown to reduce the risk of various other adverse long term health 
conditions such as obesity, vascular disease and high blood pressure (51).  
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Non-physiological benefits of exercise rehabilitation are also important to note. 
Improvement in health-related and general quality of life (14), as well as psychosocial aspects such 
as improved cognitive and social functioning, improved concentration and decreased anxiety, are 
present after exercise training in individuals with CHD (15, 16, 20). Together, physical and mental 
benefits from chronic exercise ensure well-rounded life-long care for adults and children with 
CHD. 
 
1.4.2 Exercise training modalities and prescription 
Previous studies have implemented various exercise interventions to improve peak V̇O2 
and exercise tolerance in children with CHD (1, 7, 20, 22, 35, 38, 39, 46, 49).  The most common 
exercise modality that is utilized in these studies is interval training on a cycle ergometer (1, 22, 
38). Participants complete prescribed exercise at a health care facility or are given a cycle 
ergometer to use at home (1, 22, 38). Cordina et al. (12) are among few to prescribe primarily 
resistance training exercise to participants. Supervised high-intensity total body resistance training 
exercises were completed using machines and dumbbells, with a focus on calf muscles (12). 
Brassard et al. (10) prescribed a combined aerobic and resistance training regime, utilizing interval 
training on a cycle ergometer and upper and lower body strength exercises using machines and 
dumbbells. Both Fredriksen et al. (20) and Longmuir et al. (32) implemented a different approach, 
focusing on play-based functional activities as well as educational activities intended to encourage 
behaviour change. Participants completed activities including mainstream sports such as 
swimming, volleyball, skiing and hiking (20), or motor skill activities such as frisbee throw, 
jumping up the stairs and sit to stand (32). The interventions were designed to be completed at 
home and/or in the community to increase compliance. 
Review of exercise rehabilitation studies in children with CHD shows programming 
typically is implemented 3 times per week for 30-45 minutes (1, 10, 12, 15, 38). However, length 
of programming varies greatly, ranging from 8 weeks up to 5 months. Prescribed intensity for 
exercise sessions is typically assessed using a HR monitor, with researchers providing participants 
with a specific HR range (e.g. 50-80% peak HR) to target during exercise (1, 14, 20, 38). Goldberg 
et al. (22) instructed parents or guardians of the participants to measure manual pulse rate during 
exercise. Peak V̇O2 score has also been used to determine work rate and intensity of exercise 
sessions (10, 22). Despite available evidence-based research, nationally and internationally 
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accepted exercise recommendations and guidelines for children with CHD have not been updated 
since 2011 (57). Future research is required to determine optimal exercise modalities, training 
duration, length and intensity for children with CHD. Keeping exercise guidelines and 
recommendations current and specific to CHD lesion type should also be prioritized.   
 
1.4.3 Limitations of prior work  
Adults and children with CHD are typically grouped with various other cardiac conditions 
when referred for exercise therapy. Although individuals with CHD may share anatomical and/or 
physiological similarities with other cardiovascular diseases, specific guidelines and individualized 
rehabilitation is needed to properly meet the needs of this population. Only 10% of all potential 
adult candidates for exercise rehabilitation programs actually receive therapy, and among children 
that percentage is even lower (58), highlighting the need for improvements to clinical exercise 
rehabilitation care.  
Previous studies have provided a basis for exercise prescription for children with CHD (32, 
38, 49, 57); however, future work must focus on practical programming for these children to benefit 
short and long term. For example, providing a cycle ergometer for every child with CHD is not 
viable in most communities, where the economic burden of the health care system is already 
heightened. Similarly, HR monitors, although more accurate and precise, are unlikely to be feasible 
measures of exercise intensity in real-world situations. For younger children, HR monitors may 
also require assistance from an adult, potentially increasing barriers to exercise. Compliance may 
also be an issue when using repeated cycle ergometer exercise, as constant stimulation and new 
challenges are important for children to remain engaged and motivated. Prescription guidelines are 
also lacking applicability to activities of daily living. Children rarely utilize a single exercise 
modality at one time. More often, they utilize aerobic, strength and play-based activities within the 
same day, and even to complete a single task. Future studies should prioritize exercise interventions 
that could be used in a real-world setting to properly assess the impact on exercise tolerance in 
children with CHD. 
 
1.5 Purpose, Outcomes, and Hypotheses  
The majority of research involving exercise intolerance in children with CHD has focused 
on central limitations such as cardiac output and stroke volume, and indirect measures of peripheral 
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limitations such as O2 pulse. Previous exercise interventions for children with CHD have focused 
on primarily aerobic exercise, but have not also incorporated strength training and/or play-based 
activities suitable for children to complete on a regular basis outside of a research-based 
environment. To our knowledge, there are no studies that incorporate a direct measurement of 
peripheral mechanisms of exercise intolerance using NIRS during aerobic exercise, that also 
include a well-rounded exercise intervention. Therefore, no evidence-based age-appropriate 
exercise rehabilitation program exists in Canada for children with CHD, despite widespread 
exercise rehabilitation programs available for adults with various cardiovascular issues. This 
knowledge gap should be prioritized, as exercise tolerance is the single best independent predictor 
for cardiovascular and all-cause mortality (13, 41).  
 
1.5.1 Purpose  
The purpose of this study was to determine if a 12-week home-based exercise intervention 
including strength training, aerobic exercise and play activities can improve muscle oxygenation 
(TOI) and exercise tolerance (V̇O2 and HR) during submaximal and maximal aerobic exercise in 
children with CHD compared to healthy age- and sex-matched controls (CTL). 
 
1.5.2 Primary Outcome  
The primary outcome was muscle oxygenation as measured by TOI during submaximal and 
maximal aerobic exercise. 
 
1.5.3 Secondary Outcomes  
The secondary outcomes were exercise tolerance as measured by V̇O2 and HR during 
submaximal and maximal aerobic exercise.  
 
1.5.4 Primary Hypothesis 
We hypothesized that TOI would improve post-training compared to pre-training in 
children with CHD during submaximal and maximal exercise. 
 
1.5.5 Secondary Hypotheses 
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We hypothesized that with training, V̇O2 and HR would improve when compared to pre-
training in children with CHD during submaximal and maximal exercise. We hypothesized that 
TOI, V̇O2 and HR would improve after training in children with CHD compared to healthy age- 
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CHAPTER TWO: MANUSCRIPT 
2.1 Introduction  
Despite medical advances, children with congenital heart disease (CHD) continue to exhibit 
reduced exercise tolerance compared to healthy peers, which may predispose them to 
cardiovascular disease later in life (1, 15, 20, 25, 40, 44). Mechanisms that contribute to exercise 
intolerance in children with CHD are not fully understood, resulting in a lack of practical, evidence-
based exercise programming for these children to participate in. As exercise intolerance is a major 
predictor for all-cause and cardiovascular mortality, it is vital that this knowledge gap be explored 
(15, 32). 
Both central (cardiac) and peripheral (vascular and muscle) mechanisms are known to play 
a role in reduced exercise tolerance in CHD (4, 16). Impaired central mechanisms such as cardiac 
output, stroke volume and heart rate have been attributed to reduced V̇O2, a measure of exercise 
tolerance in both children and adults with CHD (38, 45, 47). Structured aerobic exercise training 
interventions have improved these cardiac-related factors and subsequently increased peak V̇O2 (1, 
9, 21, 27, 31, 35, 39). However, exercise tolerance was still reduced when compared to healthy 
age- and sex-matched controls (9). Therefore, impaired oxygen (O2) delivery as a result of impaired 
blood flow and microvascular dysfunction, as well as reduced O2 utilization at the working muscle 
may be major peripheral determinants of reduced exercise tolerance rather than central adaptations 
(47).  
In children with CHD, few studies have examined peripheral adaptations to exercise 
training using direct measurements. Near-infrared spectroscopy (NIRS) is a commonly used 
technique to assess microvascular dysfunction in the muscle as it is a direct, reliable and valid non-
invasive measure (18, 26). NIR light monitors continuous changes in oxygenated and 
deoxygenated hemoglobin and myoglobin in the microvasculature (small arterioles, capillaries and 
venules) (6, 8, 18, 22, 25). As such, O2 delivery, availability and utilization at the muscle can be 
measured using NIRS. Tissue oxygenation index (TOI) quantifies the NIRS signal and may give 
an indication of peripheral mechanisms contributing to exercise intolerance. Few studies have 
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determined TOI in children with CHD, and thus our understanding of skeletal microvascular 
function in this patient group is limited. Moalla et al. (28) found reduced TOI, a measure of muscle 
oxygenation, in the vastus lateralis in children with CHD compared to healthy peers. After a 12-
week aerobic interval training intervention, TOI and muscle strength were shown to improve during 
isometric knee extensor exercise despite no change in V̇O2 (30). In a focused study of children with 
Fontan circulation (CHD lesion type), TOI was lower at rest and during unloaded cycling compared 
to healthy controls (46). V̇O2 was also reduced at rest and unloaded cycling, leading 
Vandekerchkove et al. (46) to speculate that both impaired O2 delivery, and the rate of O2 uptake 
contribute to reduced exercise tolerance in children with Fontan circulation (46). Further 
investigation is required to evaluate TOI during submaximal and maximal aerobic exercise with 
the addition of an exercise intervention, to determine if impaired TOI in children with CHD can be 
mitigated. By examining the relationship between TOI and V̇O2, further determinations of the 
interplay of central and peripheral factors contributing to exercise intolerance in children with CHD 
can be made.  
Structured cardiac rehabilitation programs and home-based exercise training are well 
established nonpharmacological treatments for adults and children with CHD (7, 12, 27, 30, 38, 
45). Numerous studies have shown the effectiveness of aerobic exercise training on reducing the 
effect of peripheral and central limitations contributing to exercise intolerance in children with 
CHD (1, 10, 21, 22, 27, 30, 31, 35, 38, 39). However, these interventions have not also incorporated 
both strength training and play-based activities in addition to aerobic exercise that is suitable for 
children with CHD to participate in on a regular basis outside of a research-based environment. 
The aim of this study was to determine if a 12-week home-based exercise intervention 
including strength training, aerobic exercise and play activities influenced muscle oxygenation 
(TOI) and exercise tolerance (V̇O2 and HR) during submaximal and maximal aerobic exercise in 
children with CHD. The primary hypothesis was that the 12-week home-based exercise 
intervention would improve TOI during submaximal and maximal aerobic exercise in children with 
CHD. The secondary hypothesis was that the exercise intervention would improve V̇O2 and HR 
during submaximal and maximal aerobic exercise in children with CHD, and would improve TOI, 
V̇O2 and HR compared to healthy age- and sex-matched children. 
 
2.2 Methods  
19 
 
2.2.1 Participants  
Participants included 21 children with CHD between the ages of 9-16 recruited from the 
Division of Pediatric Cardiology at the Jim Pattison Children's Hospital in Saskatoon, 
Saskatchewan. A pediatric cardiologist pre-screened patients for study eligibility and reviewed the 
home-based exercise program to ensure it was safe for all participants to complete before it was 
administered. Exclusion criteria for children with CHD included cardiac surgery within the last six 
months, inability to perform moderate to vigorous activity and inability to follow verbal commands 
related to the experimental procedures. 14 children with CHD completed both pre- and post-
program measures, and seven children with CHD completed only pre-program measures. Reasons 
for withdrawal from the study included health status, voluntary withdrawal, and proximity to study 
location. For detailed study enrolment, please refer to Figure 2.1. Nine typically developing 
children (CTL) between the ages of 9-16 were recruited through word of mouth and posters. The 
CTL group completed a one-time assessment of all measures. The CTL group did not participate 
in the exercise intervention or post-testing session, as we were interested in the CTL data only as 
a reference. Inclusion criteria for the CTL group included the absence of cardiovascular and 
respiratory disease, ability to perform moderate-vigorous activity and ability to follow verbal 
commands related to the experimental procedures. For detailed study enrolment, please refer to 
Figure 2.2. Consent was obtained from all parents and/or legal guardians (Appendix A & B) and 
assent was obtained from all children (Appendix C & D). Ethical approval was obtained from the 
University of Saskatchewan Biomedical Research Ethics Board Bio #15-148 (Appendix E).  
 
2.2.2. Anthropometric Measurements   
Anthropometric measurements for children with CHD and healthy CTL children included 
chronological age, sex, standing height, weight, and right thigh skinfold and girth. Relevant 
medical history (i.e. diagnosis, current medications, time since last cardiac-related surgical 
intervention) was obtained from medical records from the Division of Pediatric Cardiology at the 
Jim Pattison Children’s Hospital for participants with CHD.  
 
2.2.3 Pre- and Post- Program Measurements  
Participants completed a peak V̇O2 test to volitional fatigue on an electromagnetically 
braked cycle ergometer (Ergoline 800S, SensorMedics Corp, Yorba Linda, CA). Before each test, 
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flow and volume were calibrated using a 3-L capacity syringe. Gas analyzers were calibrated using 
known gas concentrations of O2 (16%) and carbon dioxide (4%). Participants were instructed to 
refrain from heavy exercise, caffeine and large meals before the test. Participants sat quietly on the 
cycle ergometer for three minutes to obtain resting baseline data. A modified Oslo protocol, 
designed for maximal exercise testing children (11, 19), was used to ensure participants could 
complete the exercise test properly by achieving at least the first two stages of the test. The 
reproducibility of this test has been validated previously (19). The test began at 25 watts for 2 
minutes, followed by 25 watts per 2-minute increments to volitional fatigue. Submaximal V̇O2 data 
was collected at 25 and 50 watts, in addition to peak V̇O2 data. Participants were provided with 
standard verbal checkups at regular intervals by the investigator. Exercise was terminated when 
participants indicated they wished to stop or if they failed to sustain a pedal rate of 65-70 
revolutions/minute. Results of the test were accepted if the respiratory exchange ratio (RER) was 
greater than 0.95. Once the test was terminated, participants continued to pedal on the ergometer 
for four minutes at 20 watts to obtain recovery data. Breath-by-breath gas exchange, HR and 
ventilation parameters were measured as the highest 30-s values within the last 1-minute of 
exercise, and submaximal parameters were measured as the average value within the last 30-s of 
stage 1 (25W) and stage 2 (50W) (SensorMedics® Vmax 229; VIASYS™ Healthcare Respiratory 
Technologies, Yorba Linda, CA, US). Beat-by-beat HR was monitored with a three-lead 
electrocardiogram (ECG), in a lead II configuration (SensorMedics® Vmax 229; VIASYS™ 
Healthcare Respiratory Technologies, Yorba Linda, CA, US).  
Muscle oxygenation (as measured by tissue oxygenation index; TOI) was measured using 
continuous-wave near-infrared spectroscopy (NIRS), with two non-stick diodes placed on the skin 
surface on the right vastus lateralis (NIRO-200NX, Hamamatsu Photonics K.K., Hamamatsu City, 
Shizuoka Pref., Japan). Placement was determined as mid-way between the femoral head and the 
lateral epicondyle. The proximal diode emits light into the tissue at three wavelengths (735, 810, 
and 850 nm), and the distal diode measures the returning wavelengths not absorbed by hemoglobin. 
Light emitted from the diode penetrates the skin, subcutaneous fat and underlying muscle and is 
either absorbed by hemoglobin or myoglobin or scattered within the tissue (17). Adipose tissue 
thickness does not alter the NIRS signal (37). The inter-diode surface distance was 3cm for all 
participants, and the depth of penetration of the near-infrared light was approximately equal to half 
the distance between the light source and the diode (17, 23). Right thigh skinfold and girth were 
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used to validate the depth of near-infrared light penetration. A thick black cloth was placed over 
the diodes to block ambient light that may interfere with the NIRS signal. A tensor bandage was 
secured over the diodes and the cloth to hold them in place during exercise. To ensure NIRS diodes 
were placed in the same location pre- and post-testing, the investigator referred to anatomical 
landmarks and anthropometric measurements taken at the diode site during preliminary testing to 
reduce pre- vs post-measurement variability. Once the peak V̇O2 test recovery period was complete, 
a blood pressure cuff was inflated on the thigh above the NIRS diodes to suprasystolic pressure 
(220 mmHg) for 3 minutes to establish the total liable signal (TLS; the difference between the 
baseline and nadir TOI). Determining the TLS allowed calibration of the physiologic TOI range, 
and changes in TOI pre- and post-training were expressed as a percentage of the TLS (Figure 2.4). 
Peak TOI (%TLS) was measured as the highest 30-s value within the last 1-minute of exercise, and 
submaximal TOI (%TLS) was measured as the average value within the last 30-s of stage 1 (25W) 
and stage 2 (50W). 
 
2.2.4 Home-Based Exercise Program  
Children with CHD completed a home-based exercise program following completion of 
preliminary measures. The program was 12 weeks long, with 30-45 minute sessions completed 3 
times per week.  The primary focus of the exercise sessions was to improve strength and aerobic 
capacity. Each exercise session included a strength component (exercises targeting the lower body), 
aerobic component (brisk walking, running, stair climbing) and a flexibility component (warm-up 
stretches). Strength exercises comprised of activities that utilized the participant's own body weight 
(no equipment was required). The 12-week exercise program was divided into 3 different phases 
of 4 weeks. In each phase, the intensity of the strength and aerobic exercises was increased for 
number and/or duration completed, and new exercises were added. Participants were provided 
detailed instructions for completing each session, including pictures and informative videos of 
specific movements (Appendix F). Participants were instructed to complete each session at or 
above a rating of perceived exertion (RPE) of 4-6 (moderate-intensity exercise). The RPE scale 
was explained in detail, and take-home information was given to participants to ensure they 
understood the RPE scale properly while exercising (Appendix F). Logbooks were given to each 
participant to record the completion of each session, the RPE level attained during the session, as 
well as any other physical activity they participated in each week (Appendix G). Participants were 
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also asked to record if they missed any sessions along with the reason they were not able to 
complete it (sickness, injury, etc.). Weekly follow-ups were conducted by phone, email and/or in-
person to aid in adherence and to facilitate questions regarding the program. Each participant was 
given the opportunity to have the researcher come to their home and complete an exercise session 
alongside them at least 1-2 times per phase, to ensure proper technique and completion of the 
exercise sessions. Participants who resided further than 100km away from the testing site did not 
receive an in-person exercise session. 
 
2.2.5 Biweekly Sessions  
In addition to the home-based exercise program, participants attended six biweekly in-
person sessions as part of a larger intervention program, CHAMPS camp, at the University of 
Saskatchewan Physical Activity Complex in Saskatoon, Saskatchewan, and the YMCA in Regina, 
Saskatchewan. These sessions were 3-4 hours in length and supplemented the 12-week exercise 
program. The program had a multidisciplinary approach, including mental wellness and physical 
literacy sessions along with physical activity promotion in the form of play activities. For the 
purposes of this study, only the physical activity portion of these sessions is considered when 
interpreting results. Play activities included swimming, rock climbing, yoga, gymnastics, and 
sports such as basketball and volleyball. In addition, each participant completed 20 minutes of 
aerobic exercise on a cycle ergometer, and were asked to exercise at an RPE intensity of 4-6 (scale 
was visually presented to them). The participants then completed 15-minutes of resistance training 
led by the investigator, including similar and/or different exercises than the home-based exercise 
program. Similar to the home-based program, exercise was primarily lower-body resistance 
exercise. The upcoming two weeks of the home-based program was reviewed with the participants, 
and any new exercises or progressions were demonstrated. 
 
2.2.6 Data Analysis  
The primary outcome was TOI measured by NIRS on the right vastus lateralis. The 
secondary outcomes were exercise tolerance measured by peak V̇O2 and HR. Based on previously 
reported muscle oxygenation values in children with CHD (46), sample size calculation using 
G*Power 3.1.9.1 (Franz Faul, Kiel University, Germany) yielded a sample size of 15 participants 
(1-b = 0.8, a = 0.05, ES = 0.8). TOI was expressed as a percentage scaled to the TLS based on the 
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highest 5-s average at baseline (100%) and the lowest 5-s value at the nadir during circulatory 
occlusion of the right thigh (0%). Peak TOI, V̇O2 and HR were analyzed as the average value over 
30-s over the last 1-minute of exercise. Submaximal TOI, V̇O2 and HR were analyzed as the 
average of the last 30-s of stage 1 (25W) and stage 2 (50W).  Pre- versus post-training changes in 
TOI, V̇O2 and HR were analyzed using paired t-tests (SigmaPlot v13.0, Systat Software Inc. San 
Jose, CA, USA). If the assumption of homogeneity was violated, nonparametric Wilcoxon signed-
rank test was used. Between-group differences were assessed using one-way ANOVAs with Holm 
Sidak post-hoc tests (SigmaPlot v13.0, Systat Software Inc. San Jose, CA, USA). Kruskal-Wallis 
one-way ANOVA nonparametric testing was used where the assumption of homogeneity of 
variances was violated. Cohen’s d value for effect size was reported to describe the meaningfulness 
of the data. Data are reported as mean ± standard deviation, and p<0.05 was considered statistically 
significant.  
 
2.3 Results  
2.3.1 Demographics 
 Age was not significantly different between CHD and CTL groups (Table 2.1). Although 
not significant, standing height, weight and BMI tended to be higher pre- and post-training in 
children with CHD compared to CTL (Table 2.1). CHD type, severity, time since last cardiac-
related surgical intervention and cardiac-related medications are listed in Table 2.2. HR was 
significantly lower at baseline in CHD pre- and post-training compared to CTL (84±12 bpm vs 
95±13 bpm; 81±11 bpm vs 97±11 bpm; p = 0.02; Table 2.3). There were no significant differences 
in baseline relative or absolute V̇O2, TOI or VE (Table 2.3). Figure 2.3 shows representative data 
for TOI, V̇O2, HR and work rate.  
 
2.3.2 Adherence  
 Adherence to the home exercise program and biweekly sessions were expressed as a 
percentage of sessions completed. Average adherence to the home-based exercise program was 
68±32%. Nine participants completed >80% of the exercise sessions, and four participants 
completed <50% of the exercise sessions. Average attendance to the biweekly sessions was 
77±28%. Ten participants attended >80% of the biweekly sessions, and two participants attended 




2.3.3 Effect of exercise training on TOI at peak V̇O2  
Although not significant, TOI average at V̇O2 peak was lower post-training compared to 
pre-training in children with CHD (20±13% vs 30±16%; p = 0.09, d = 0.66; Figure 2.5). TOI 
average at V̇O2 peak was not significantly different in children with CHD pre-training compared 
to healthy CTLs (30±16% vs 41±11%; p = 0.11, d = 0.82; Figure 2.5). Post-training, children with 
CHD had significantly lower TOI at peak V̇O2 compared to CTLs (20±13% vs 41±11%; p = 0.02, 
d = 1.33; Figure 2.5). 
 
2.3.4 Effect of exercise training on submaximal TOI   
There was no significant difference pre- vs post-training TOI during stage 1 of exercise 
(25W) (76±20% vs 73±19%; p = 0.60, d = 0.13; Figure 2.6). Although not significant, TOI at stage 
2 of exercise (50W) was lower post-training compared to pre-training (47±26% vs 62±20%; p = 
0.06, d = 0.59; Figure 2.7). TOI at stage 1 was not significantly different in children with CHD pre- 
or post-training (76±20% vs 83±11%, d = 0.45; 73±19% vs 83±11%, d = 0.62; p = 0.68; Figure 
2.6) compared to CTLs. TOI at stage 2 was not significantly different in children with CHD pre- 
or post-training (62±20% vs 70±16%, d = 0.49; 47±26% vs 70±16%, d = 0.95; p =0.16; Figure 2.7) 
compared to CTLs. 
 
2.3.5 Effect of exercise training on peak V̇O2  
There was no significant difference pre- vs post-training in relative peak V̇O2 (35±7 
mL/kg/min vs 36±9 mL/kg/min; p = 0.56, d = 0.10; Figure 2.8) or absolute peak V̇O2 (1.85±0.39 
L/min vs 1.93±0.43 L/min; p = 0.33, d = 0.19; data not shown) in children with CHD. Relative 
peak V̇O2 pre- and post- training in children with CHD was significantly lower compared to healthy 
CTLs (35±7 mL/kg/min vs 48±7 mL/kg/min; p = 0.006, d = 1.28; 36±9 mL/kg/min vs 48±7 
mL/kg/min; p = 0.005, d = 1.16; Figure 2.8). There was no significant difference in absolute peak 
V̇O2 pre- or post- training (1.85±0.39 L/min vs 1.81±0.40 L/min, d = 0.10; 1.93±0.43 L/min vs 
1.81±0.40 L/min, d = 0.28; p = 0.83; data not shown) in children with CHD compared to healthy 
CTLs.    
 
2.3.6 Effect of exercise training on submaximal V̇O2  
25 
 
There was no significant difference in relative V̇O2 at stage 1 (16±4 mL/kg/min vs 16±3 
mL/kg/min; p = 0.87, d = 0.04; Figure 2.9) or stage 2 (22±4 mL/kg/min vs 23±5 mL/kg/min; p = 
0.52, d = 0.11; Figure 2.10) pre- vs post- training in children with CHD. There was no significant 
difference in absolute V̇O2 at stage 1 (0.84±0.14 L/min vs 0.85±0.10 L/min; p = 0.43, d = 0.09; 
data not shown) or stage 2 (1.15±0.16 L/min vs 1.18±0.10 L/min; p = 0.46, d = 0.25; data not 
shown) pre- vs post- training in children with CHD. In children with CHD, pre- and post- training 
relative V̇O2 was significantly different compared to CTLs at stage 1 (16±4 mL/kg/min vs 21±3 
mL/kg/min, d = 1.10; 16±3 mL/kg/min vs 21±3 mL/kg/min, d = 1.27; p = 0.01; Figure 2.9). 
Absolute V̇O2 in children with CHD pre- and post-training compared to CTLs was not significantly 
different at stage 1 (0.84±0.14 vs 0.79±0.08 L/min, d = 0.42; 0.85±0.10 vs 0.79±0.08 L/min, d = 
0.62; p = 0.51; data not shown). In children with CHD, relative V̇O2 at stage 2 was significantly 
lower pre- (22±4 mL/kg/min vs 31±8 mL/kg/min; p = 0.006, d = 1.19; Figure 2.10) and post- 
training (23±5 mL/kg/min vs 31±8 mL/kg/min; p = 0.01, d = 1.13; Figure 2.10) compared to CTL. 
Pre- and post- training absolute V̇O2 at stage 2 (1.15±0.16 L/min vs 1.20±0.16 L/min, d = 0.31; 
1.18±0.10 L/min vs 1.20±0.16 L/min, d = 0.12; p = 0.76; data not shown) in children with CHD 
compared to CTLs was not significantly different. 
 
2.3.7 Effect of exercise training on HR at peak V̇O2 
HR at peak V̇O2 was not significantly different pre- vs post-training (175±23 bpm vs 
169±21 bpm; p = 0.18, d = 0.27; Figure 2.11) in children with CHD. Although not significant, HR 
at peak V̇O2 was lower in children with CHD compared to CTLs pre- and post-training (175±23 
bpm vs 189±12 bpm, d = 0.74; 169±21 bpm vs 189±12 bpm, d = 1.03; p = 0.06; Figure 2.11).  
 
2.3.8 Effect of exercise training on submaximal HR 
 There were no significant differences pre- vs post- training HR at stage 1 (111±16 bpm vs 
108±11 bpm; p = 0.34, d = 0.22; Figure 2.12) or stage 2 (130±12 bpm vs 126±16 bpm; p = 0.20, d 
= 0.33; Figure 2.13s) in children with CHD. At stage 1, pre- (111±16 bpm vs 127±18 bpm; p = 
0.04, d = 0.89; Figure 2.12) and post- training HR (108±11 bpm vs 127±18 bpm; p = 0.03, d = 
1.11; Figure 2.12) was significantly lower in children with CHD compared to CTL. Similarly, pre- 
(130±12 bpm vs 147±18 bpm; p = 0.04, d = 0.96; Figure 2.13) and post- training (126±16 bpm vs 
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147±18 bpm; p = 0.02, d = 1.07; Figure 2.13) HR at stage 2 was significantly lower in children 
with CHD compared to CTL.  
 
2.4 Discussion  
 The purpose of this study was to determine if a 12-week home-based exercise intervention 
improved TOI, V̇O2 and HR during submaximal and maximal aerobic exercise in children with 
CHD. The major novel finding of this study is that, contrary to previous research, TOI at maximal 
exercise (peak V̇O2) was lower after a resistance training intervention in children with CHD 
compared to pre-training values and healthy CTLs. This response was despite no significant 
changes in peak V̇O2 or HR, indicating a change in O2 utilization without a change in O2 delivery. 
To our knowledge, this is the first study to suggest peripheral mechanisms that contribute to 
exercise intolerance in children with CHD can be isolated and altered using a home-based strength 
training intervention. 
   
2.4.1 TOI responses to exercise training in children with CHD  
 Our study demonstrated for the first time an exaggerated decrease in TOI at maximal and 
submaximal aerobic exercise after a strength-based exercise intervention in children with CHD. 
TOI reflects the balance between O2 delivery and utilization (23). During exercise, TOI transiently 
decreases as O2 is utilized at the muscle to meet increased metabolic demands in healthy individuals 
(5). In children with CHD, this response has been shown to be impaired compared to healthy age- 
and sex-matched peers due to various mechanisms contributing to reduced O2 delivery and uptake 
at the working muscle, causing TOI to decrease to lower values during exercise (28, 29, 41, 46). 
Aerobic exercise interventions have been used to mitigate impaired exercise TOI contributing to 
exercise intolerance in these children, and reducing the disparity compared to healthy peers (30, 
31). Moalla et al. (30) associated improvements in muscle oxygenation after an aerobic interval 
training program to both central (cardiac output) and peripheral (arteriovenous O2 difference and 
capillary density) adaptations. Conversely, the present study demonstrated an augmented TOI 
decrease at maximal exercise, as well as stage 2 of submaximal exercise post-training. To our 
knowledge, this has not been demonstrated previously in children with CHD. Costes et al. (14) 
showed significant decreases in muscle oxygenation during submaximal exercise in young healthy 
males after an aerobic exercise intervention, with no change in V̇O2. Muscle biopsies obtained from 
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the vastus lateralis determined the decrease in TOI post-training was due to increased 
capillarization and oxidative enzyme capacity at the muscle, enhancing the matching of capillary 
flow to metabolic demand (14). Due to the enhancement of capillary flow, without a concurrent 
increase in O2 delivery TOI was further decreased post-training (14). Similar results were 
demonstrated in a group of competitive cyclists during a submaximal endurance test after an 
interval training program (33). More recently, a study in COPD patients and healthy sedentary 
participants showed training-induced increases in skeletal muscle aerobic capacity without relevant 
changes in muscle blood volume, due to enhancement of the muscle capillary network and 
mitochondrial respiratory capacity (2). Although difficult to compare our findings due to differing 
participant group characteristics and exercise interventions, these mechanisms may prove as a 
starting point to explain our further impaired TOI response to exercise post-training in children 
with CHD. Indeed, as our exercise intervention focused on lower-body resistance training, one can 
infer that increases in muscle mass and strength occurred as a result. Coupled with significant 
changes in TOI observed post-training, we conclude that our intervention elicited adaptations in 
the periphery independent of changes in O2 delivery, similar to those highlighted by Costes et al. 
(14). Thus, resulting in a greater disparity between oxygen delivery and utilization at the working 
muscle post-training in our CHD participants.  
The use of the total liable signal (TLS) when analyzing muscle oxygenation data from NIRS 
provides an indication that changes in TOI pre- vs post-training in children with CHD are due to 
microvascular adaptations to training and not baseline TOI values. Previous studies that have used 
NIRS to evaluate TOI have not included TLS, which leads one to speculate whether the magnitude 
of change in TOI (either increase or decrease) is related to the relative baseline TOI level for each 
participant. In the present study, calibration of the physiologic TOI range via TLS allowed reliable 
comparisons and generalizations regarding peripheral responses to exercise training. This suggests 
our novel exercise intervention was successful in isolating and determining peripheral mechanisms 
associated with exercise intolerance in children with CHD.  
 
2.4.2 V̇O2 responses to exercise training in children with CHD 
There were no significant differences pre- vs post-training in submaximal or maximal V̇O2 
in children with CHD. Previous work has not yet led to a consensus for the intervention required 
to elicit significant V̇O2 increases in children with CHD.  Many have shown aerobic interval 
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training elicits increases in peak V̇O2 of 3-4 mL/kg/min (1, 22, 30). However, others have shown 
no change in peak V̇O2 after similar training (10). Cordina et al. (13) implemented a resistance 
training program that showed a significant increase of absolute peak V̇O2 of 0.5 L/min, and Rhodes 
et al. (38) showed an increase in peak V̇O2 of approximately 4.0 mL/kg/min after a combined 
aerobic and strength training intervention. Similarly, our study included primarily resistance-based 
exercise supplemented with aerobic training; however, it did not elicit significant changes in V̇O2. 
Our exercise intervention was designed to address our primary purpose of eliciting changes in the 
periphery that may contribute to exercise intolerance in children with CHD, rather than improving 
maximal performance. It is also possible that disproportional adaptations to exercise training in our 
study, characterized by significant changes in TOI without changes in V̇O2, may have masked 
central hemodynamic changes, if any.   
Exercise intensity may be an important factor in our results. Intensity is widely regarded as 
the most important determinant of an exercise prescription’s effectiveness for increasing V̇O2 (43).  
Unlike previous studies, our intervention only used an RPE scale to monitor intensity, as our 
program was designed to be feasible and easy for children to follow. Rhodes et al. (38) used HR at 
the ventilatory threshold as a target exercise intensity for participants. They were also able to more 
closely monitor their participants, with supervised exercise sessions two times per week for 12 
weeks, compared to our intervention where supervised exercise only occurred every two weeks. 
Therefore, our method of self-reported intensity may not have had a strong enough stimulus to 
influence central hemodynamic factors, such as cardiac output, that contribute to V̇O2.   
Our CHD participant characteristics may have also contributed to the absence of significant 
V̇O2 changes. Our group consisted of a heterogeneous sample of CHD lesion types, including both 
simple (Atrial Septal Defect, Bicuspid Aortic Valve, Coarctation of the Aorta, Pulmonary Stenosis, 
Ventricular Septal Defect), and complex lesions (Congenitally Corrected Transposition of the 
Great Arteries, Dextro-Transposition of the Great Arteries, Double Inlet Left Ventricle, Tetralogy 
of Fallot). Various central hemodynamic factors can be implicated as a result of lesion structure 
and morphology such as cardiac output, heart rate, left ventricular ejection fraction and atrial and 
ventricular pressure (3). As a result, lesion type and severity are a major determinant of V̇O2 for 
individuals with CHD (25), thus the effectiveness of an exercise intervention. Numerous studies 
involving homogeneous samples of children with complex CHD lesions consistently show 
improvements in both submaximal and maximal V̇O2 post-training, due to improved central 
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hemodynamic factors such as cardiac output, stroke volume and diastolic blood pressure (13, 27, 
35, 38). In contrast, exercise interventions including a heterogeneous sample of both simple and 
complex lesions see little to no improvement in V̇O2 (21, 22). Exploratory analysis of our data 
revealed participants with complex lesions tended to have a lower exercise tolerance (peak V̇O2) 
both pre- and post-training compared to participants with simple lesions. This may have also 
contributed to the lack of change in V̇O2 after training, as our program was not specifically tailored 
to lesion type. However, due to an already low sample size, subgroup analyses are taken with 
caution. Future work should consider examining the effects of our exercise intervention on a 
homogenous group of CHD type or creating simple and complex lesion subgroups within a 
heterogeneous sample to determine altogether the effects of resistance training on V̇O2 during 
submaximal and maximal aerobic exercise in children with CHD.  
 
2.4.3 Heart rate responses to exercise training in children with CHD 
In children with CHD, HR was not significantly different during submaximal or maximal 
exercise pre- vs post-training. Children with CHD are unique in that lesion type and severity can 
play a major role in the ability to increase HR during exercise (34).  Chronotropic incompetence, 
the inability to increase HR to normal levels during exercise, is common after surgery for various 
types of CHD (34). In addition, three CHD participants had a pacemaker device (Table 2.2) which 
may also prevent appropriate increases in HR in response to training. Previous work has shown in 
homogenous participant samples, heart rate responses can be improved as a result of training (42, 
48). As our sample varies in the time since last cardiac surgical intervention, it is possible that our 
participants had differing levels of chronotropic incompetence impairing adaptation of HR to 
exercise training, therefore any improvements in HR may have been masked.   
 
2.4.4 Role of O2 flux on central and peripheral responses to exercise training 
The role of O2 flux may be an important factor to consider in TOI, V̇O2 and HR responses 
to exercise training in children with CHD. O2 flux describes changes in arterial-venous O2 content 
difference (A-V O2) due to the rate of O2 offloading from the blood to the working muscle. O2 flux 
is influenced by many factors such as mitochondrial volume density, capillary density and function, 
red blood cell velocity, O2 delivery and capillary to fibre ratio (24, 36). To our knowledge, none 
have characterized O2 flux or A-V O2 difference directly in children with CHD. In patients with 
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heart failure, O2 flux has been shown to be impaired due to compromised microcirculatory function 
such as decreased capillary and mitochondrial density, decreasing the ability of O2 to offload at the 
muscle (24, 36).  Exercise training has been shown to improve blood-muscle O2 transfer and 
increase A-V O2 difference during exercise in patients with heart failure (24). Similarly, our 
exercise intervention may have elicited increases in capillary number and density, slowing blood 
flow at the working muscle and allowing for an increase in O2 offloading from the blood to the 
muscle. With an increase in mitochondrial density, the muscle would be able to use the increased 
amount of O2 available more efficiently to match metabolic demand, and A-V O2 difference and 
subsequently TOI would increase. However, our results suggest that there was not a parallel 
increase in O2 delivery with increased O2 utilization (no change in V̇O2 or HR). The decreased TOI 
or O2 content of the muscle post-training in children with CHD may be explained by an improved 
O2 flux via increased O2 extraction and utilization, without a subsequent increase in O2 delivery to 
match. Further work is needed to determine the mechanisms behind this unique response, and to 
further investigate O2 flux in children with CHD. 
 
2.4.5 Effectiveness of the home-based exercise program 
Our novel strength-based home-exercise intervention demonstrated for the first time that a 
program designed for research methodology as well as real-world application may be able to elicit 
positive peripheral adaptations related to exercise intolerance in children with CHD. Previous 
studies have primarily implemented aerobic-based exercise interventions (1, 22, 27, 30), likely due 
to ease of program implementation and the ability of these programs to produce significant 
improvements in exercise tolerance. Although both important, it is difficult to generalize these 
results and translate them into feasible clinical rehabilitation programs. By including primarily 
lower body strength exercises related to functional movement patterns, and supplementing it with 
aerobic and play components, our study addressed key aspects of daily activities for children with 
CHD. Our study successfully addressed a gap in the field of exercise rehabilitation for children 
with CHD. By developing our program so as to provide a feasible exercise intervention to ensure 
results were applicable to activities of daily living strengthened the impact our results may have on 
future studies.  
 
2.4.6 Participant characteristics   
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As expected, children with CHD increased in height and weight over the 12-week training 
period, neither of which was significantly different compared to CTL. Although not significant, 
our CTL group was smaller in height and weight and had a BMI 2 kg/m2 lower than the CHD 
group. There were no significant differences in right thigh girth between groups; however, right 
thigh skinfold thickness was significantly different pre- vs post-training in children with CHD. 
Skinfold thickness was approximately 3mm lower post-training compared to pre-training, which 
may indicate an increase of lean mass at the measurement site. Pre-training skinfold thickness in 
children with CHD was significantly higher compared to CTL. Coupled with fairly high peak V̇O2 
scores, our reference CTL group may have represented a high fit healthy population. Future studies 
should ensure a more representative CTL group is used or consider utilizing low-fit and high-fit 
groups to allow more precise comparisons between CTL and CHD participants.  
 
2.5 Conclusion  
 Our study demonstrated for the first time in a heterogeneous group of children with CHD 
that a home-based exercise intervention including strength, aerobic and play activities reduced 
submaximal and maximal TOI compared to pre-training values in children with CHD and healthy 
age- and sex-matched CTLs. The reduction in TOI, combined with a lack of change in V̇O2 and 
HR at submaximal and maximal exercise, points to a potential mismatch of central and peripheral 
adaptations in response to exercise training. These findings show that resistance training has the 
ability to mitigate peripheral mechanisms associated with exercise intolerance in children with 
CHD. These findings provide further evidence for the effectiveness of exercise rehabilitation to 
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Table 2.1 Participant demographics. 








Age (yrs)  12±2  12±2  12±3  0.80 
Sex (f:m)  5:9  -  5:4  - 
Height (cm)  154±13  156±13  149±13  0.43 
Weight (kg)  48±14  49±14  41±12  0.27 
BMI (kg/m2 )  20±4  20±4  18±3  0.44 
Reside (U:R)  9:5  -  9:0  - 
R Thigh Girth (cm)  46±7  46±7  43±7  0.62 
R Thigh Skinfold 
Thickness (mm) 
 






Values are mean ± SD. CHD, Congenital Heart Disease; CTL, controls; BMI, body mass index;  



















Table 2.2 CHD participant characteristics.  
  Diagnosis 
 
Surgical Intervention (s)  








CHD02  PV Stenosis  Balloon valvuloplasty  12  I  - 
CHD06  d-TGA  
Balloon atrial septostomy, arterial 
switch, RVOT patch, balloon branch 
pass 
 10  I  - 
CHD15  TOF  
VSD patch, RVMB resection, 
pulmonary valvuloplasty 






Gortex shunt, bidirectional Glenn, 
Fontan 
 10  I  ASA 
CHD25  CoA  
End to end CoA repair, balloon 
reCoA 
 13  I  - 
CHD27  PV stenosis, ASD  
Balloon valvuloplasty, ASD closure, 
TV repair 
 8  I  - 
CHD28  cc-TGA  ASD closure, pacemaker  1  I  ASA 
CHD34  TOF  
Right Blalock Taussig shunt, TOF 
repair 
 13  I  - 
CHD38  TOF, right arch  TOF repair, PV replacement   14  I  ASA 
CHD41  TOF  TOF repair, pacemaker  16  I  - 
CHD59  VSD, heart block   VSD patch, pacemaker  4  I  - 
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CHD60  d-TGA, VSD  
Arterial switch, VSD patch, CoA 
repair, ASD suture 





Right & left Blalock-Taussig shunt, 
Nikaidoh procedure 
 12  I  - 
CHD73  
CoA, VSD, PDA, 




End to end CoA repair, VSD closure, 
PA banding & debanding, RVMB 
resection 




 AVSD repair  5  I  - 
CHD78  CoA, BAV  End to end coarctation repair  10  I  - 
 
PV, Pulmonary valve; d-TGA, Dextro-Transposition of the Great Arteries; RVOT, right ventricular outflow tract; TOF, Tetralogy of 
Fallot; VSD, Ventricular Septal Defect; RVMB, right ventricular muscle band; DILV, Double Inlet Left Ventricle; CoA, Coarctation of 
the Aorta; ASD, Atrial Septal Defect; TV, Tricuspid valve; cc-TGA, Congenitally Corrected Transposition of the Great Arteries; PDA, 















 CTL  p-value 
HR (beats/min)  84±12  81±11  97±11  0.02* 
V̇O2 (mL/kg/min)  6.8±1.4  6.8±1.9  7.9±1.4  0.15 
V̇O2 (L/min)  0.4±0.1  0.4±0.1  0.3±0.1  0.24 
VE (L/min)  11.8±1.9  11.8±2.5  11.8±3.1  0.91 
Relative TOI (%)  73±3  70±4  74±3  0.08 
Absolute TOI (%TLS)  100±0.08  100±0.19  100±0.02  0.48 
 
Values are mean ± SD. CHD, Congenital Heart Disease; CTL, controls; HR, heart rate; V̇O2 , 
oxygen consumption; VE, ventilation; TOI, tissue oxygenation index; TLS, total liable signal. 
































































 Lost to follow-up (n=6) 
-3 Refused testing  






maximal TOI  
 
Children with CHD 
contacted to participate  
(n=49)  
Excluded (n=27) 
- Declined to participate 
(distance to study location, etc.) 








-4 Insufficient peak test  
-3 Signal error 
Excluded (n=4) 
-4 Insufficient peak test 
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-4 Insufficient peak test 











































-Did not complete peak V̇O2 test 
Submaximal & 














































Figure 2.3: Representative data.
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Figure 2.5: Tissue oxygenation index (TOI) at peak V̇O2. Pre- and post- training TOI at peak V̇O2 
in children with CHD (n = 7) compared to CTL (n = 7). *Post-training significantly lower compared 
to CTL (p = 0.02; d  = 1.33). Pre- vs post-training (p = 0.09; d = 0.66), pre-training vs CTL (p = 





















Figure 2.6: Submaximal tissue oxygenation index (TOI) at stage 1 (25W). TOI at stage 1 pre- and 
post- training in children with CHD (n = 7) compared to CTL (n = 7). Pre- vs post-training (p = 
0.60; d = 0.13), pre-training vs CTL (p = 0.68; d = 0.45), post-training vs CTL (p = 0.68; d = 0.62). 



























Figure 2.7: Submaximal tissue oxygenation index (TOI) at stage 2 (50W). TOI at stage 2 pre- and 
post- training in children with CHD (n = 7) compared to CTL (n = 7). Pre- vs post-training (p = 
0.06; d = 0.59), pre-training vs CTL (p = 0.16; d = 0.49), post-training vs CTL (p = 0.16; d = 0.95). 





























Figure 2.8: Relative peak V̇O2 (mL/kg/min). Pre- and post- training relative peak V̇O2 in children 
with CHD (n = 10) compared to CTL (n = 8). *CTL significantly higher than pre- (p = 0.006; d = 
1.28) and post-training (p = 0.005; d = 1.16). Pre- vs post-training (p = 0.56; d = 0.10). Values are 


























Figure 2.9: Submaximal V̇O2 (mL/kg/min) at stage 1 (25W). Pre- and post-training V̇O2 at stage 1 
in children with CHD (n = 10) compared to CTL (n = 8). *CTL significantly higher compared to 
pre- (p = 0.01; d = 1.10) and post-training (p = 0.01; d = 1.27). Pre- vs post-training (p = 0.87; d = 




























Figure 2.10: Submaximal V̇O2 (mL/kg/min) at stage 2 (50W). Pre- and post-training V̇O2 at stage 
2 in children with CHD (n = 10) compared to CTL (n = 8). *CTL significantly higher compared to 
pre- (p = 0.006; d = 1.19) and post-training (p = 0.01; d = 1.13). Pre- vs post-training (p = 0.52;  d 





























Figure 2.11: Heart rate (HR) at peak V̇O2. Pre- and post- training HR at peak V̇O2 in children with 
CHD (n = 9) compared to CTL (n = 8). Pre- vs post-training (p = 0.18; d = 0.27), pre-training vs 



























Figure 2.12: Submaximal heart rate (HR) at stage 1 (25W). Pre- and post- training HR at stage 1 
in children with CHD (n = 9) compared to CTL (n = 8). *CTL significantly higher compared to 
pre- (p = 0.04; d = 0.89) and post-training (p = 0.03; d = 1.11). Pre- vs post-training (p = 0.34; d = 




























Figure 2.13: Submaximal heart rate (HR) at stage 2 (50W). Pre- and post- training HR at stage 2 
in children with CHD (n = 9) compared to CTL (n = 8). *CTL significantly higher compared to 
pre- (p = 0.04; d = 0.96) and post- training (p = 0.02; d = 1.07). Pre- vs post-training (p = 0.20; d = 





CHAPTER THREE: DISCUSSION 
3.1 Main Findings  
 For the first time, we characterized TOI, V̇O2 and HR responses in children with CHD 
during submaximal and maximal exercise before and after a novel exercise intervention including 
primarily lower-body resistance training, supplemented with aerobic and play exercises.  We 
found, contrary to previous research, that TOI was further decreased during exercise post-training 
compared to pre-training in children with CHD and compared to healthy CTLs. This response was 
demonstrated at maximal exercise (peak V̇O2), as well as submaximal exercise (stage 2, 50W). The 
exaggerated TOI decrease occurred without significant changes in submaximal or maximal V̇O2 or 
HR post-training, indicating a potential imbalance between central and peripheral adaptations to 
strength-based exercise training in children with CHD.  
 Our findings suggest that peripheral mechanisms associated with exercise intolerance in 
children with CHD can be isolated and manipulated using a strength-based exercise intervention. 
Our results add important information to a limited research area. The ability to determine 
mechanisms that may improve exercise tolerance, and subsequently isolate them is a vital tool in 
effective exercise rehabilitation for children with CHD.    
 
3.1.1 Exercise adaptations in children with CHD compared to CTL  
Comparing children with CHD to healthy peers serves as a benchmark for intervention 
effectiveness. In the present study, TOI was higher at all exercise time points in CTL compared to 
CHD. As we expected, our CTL group had little impairment in central (cardiac output, stroke 
volume) or peripheral (microvascular dysfunction) factors that may affect their ability to exercise. 
Despite no significant differences pre-training, post-training maximal TOI in children with CHD 
was significantly lower than CTL with a large effect size. This was contrary to our hypothesis, 
where we expected our exercise intervention to improve TOI values in children with CHD 
compared to CTL. This has not yet been demonstrated in children with CHD; however, it has been 
shown in healthy individuals. Both in young healthy males (5) and competitive cyclists (17), TOI 
decreased to lower levels during exercise after an exercise intervention. Similar to both Costes et
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 al. (5) and Neary et al. (17) we attribute our further impaired TOI response post-training to 
peripheral factors such as improved capillary and mitochondrial density, resulting in an increased 
O2 flux and A-V O2 difference. Our results are a positive indication that peripheral mechanisms 
can be altered in children with CHD similarly to that of healthy individuals.   
 Submaximal and maximal V̇O2 was unchanged pre- vs post-training in children with CHD. 
However, compared to our CTL group, children with CHD had a significantly lower peak V̇O2, as 
well as V̇O2 at stage 1 and 2 pre- and post-training, with large effect sizes. Our CTL group had an 
average peak V̇O2 of 48 mL/kg/min, representing a high fit sample which may have influenced our 
data comparisons. Previous studies have included a non-training group of children with CHD to 
act as the CTL group instead of healthy children (8, 15). In doing this, baseline V̇O2 levels were 
more closely matched, and comparisons were more applicable to specific CHD lesion type. 
However, comparisons to individuals without altered cardiac morphology are valuable in 
attempting to bridge the gap in exercise tolerance. Previous work has shown individuals with CHD 
tend to have peak V̇O2 values 50% lower than that of healthy age- and sex-matched controls (11). 
As exercise tolerance is a significant predictor of mortality (6, 16), future studies should continue 
to compare CHD and healthy CTL groups, and include better matching of physical activity between 
groups.   
Similarly, despite no change in HR pre- vs post-training in children with CHD, HR at peak 
V̇O2, as well as stages 1 and 2, was lower pre- and post-training in children with CHD compared 
to CTL. This may be explained by differing baseline fitness levels, in addition to the cardiovascular 
structural differences present. Chronotropic incompetence is common in individuals with CHD 
(18); therefore, it may be more useful to compare HR responses to exercise training to a control 
group of children with CHD. Three CHD participants had a pacemaker, which may further 
influence HR responses to exercise. Therefore, our HR results are taken with caution.  
 
3.2 Strengths of Exercise Prescription    
Currently, there is no pediatric cardiac rehabilitation program established in Canada. Our 
study aim was to create an exercise intervention that would be effective in improving exercise 
tolerance, in addition to creating an enjoyable active environment for children with CHD. There 
are a limited number of studies that have designed their intervention around these considerations. 
Longmuir et al. (13) implemented a program focused on real-world play-based activities in addition 
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to healthy lifestyle education in a sample of children with the Fontan circulation (a complex CHD 
type). Although the program improved motor skill and moderate-vigorous physical activity 
minutes, there was no change in peak V̇O2 (13). This was likely due to the absence of a fitness 
training component within the program (13). Rhodes et al. (20) not only prioritized play-based 
activities, but also included bodyweight aerobic exercise and resistance exercise using weights and 
elastic bands in a heterogeneous group of children with CHD. The intervention increased peak V̇O2 
by approximately 4 mL/kg/min (20), but did not directly measure peripheral mechanisms 
associated with exercise tolerance. The present study included similar components of exercise 
prescription and improved upon them by including gold standard direct measurements of central 
(V̇O2) and peripheral (TOI via NIRS) mechanisms associated with exercise tolerance. In addition, 
through observing measures during both submaximal and maximal exercise we covered a broad 
spectrum of exercise intensities that may be used for various tasks throughout daily life and 
therefore enhanced the applicability of our results. Our intervention also included lower-body 
resistance exercises that are important for numerous daily activities such as climbing stairs and 
playing on the playground. Using the results from our study, we are able to better understand how 
both peripheral and central mechanisms play a daily role in reduced exercise tolerance in children 
with CHD. 
Accessibility was a strength of our exercise intervention. As many families with children 
with CHD live in rural and remote communities in Saskatchewan, they face additional barriers that 
need to be taken into account when designing an exercise program. Home-based exercise 
programming allowed our intervention to benefit a larger demographic in our province. 
Specifically, the sessions included bodyweight exercises and did not require large amounts of space 
to lessen the barriers of socio-economic status. In turn, we also aimed to give ample alternative 
options for exercise progressions. Education on household items that could be used to increase the 
intensity of an exercise gave the children an opportunity to be resourceful as well as creative in 
their own physical activity.   
Our exercise program was straightforward and designed to be easy to understand for 
children and their parents. Children were given booklets with step-by-step instructions for each 
session to encourage independence and ownership of their own fitness. Exercise intensity followed 
descriptive ratings of perceived exertion scale, instead of heart rate range (7–9), dyspnea threshold 
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(1) or percentage of peak V̇O2 (4, 15) to avoid the reliance on parents/guardians to measure exercise 
intensity. This was also a key component in maintaining compliance to the program.  
Parents, other family members, and friends were encouraged to get involved in the exercise 
program. Involving a social aspect to the program aided in motivation and compliance for those 
children who had additional supports. For children who completed the programming on their own, 
follow-ups and in-person sessions were prioritized to help guide them through the intervention.   
Our patient-focused exercise intervention can serve as a model for future programs. 
Ensuring that the intervention can be applied to real-world programming and also translate into 
exercise tolerance benefits should be at the forefront of future study design of exercise prescription 
for children with CHD.   
 
3.3 Clinical Relevance  
The current study has the potential to influence future chronic disease management 
programming for children with CHD. We have shown that practical exercise programming, 
completed in the convenience of the participant's home may be effective in mitigating peripheral 
mechanisms related to exercise intolerance in children with CHD. Further investigation of these 
mechanisms before and after exercise training will aid in ensuring rehabilitation is effective in 
targeting and improving exercise limitations for these children. We demonstrate that the balance 
between creating an intervention focused on improving patient access and program feasibility, in 
addition to an intervention suitable for research design is possible. We hope that this program can 
serve a greater purpose as a model for a CHD-specific exercise rehabilitation program, as well as 
specific exercise guidelines for children with CHD. Development of such programs should be a 
priority, to ensure the health and well-being of the increasing population of individuals with CHD.  
 
3.4 Areas for Improvement 
3.4.1 Sample size and participant characteristics  
The size of our sample could be perceived as a limitation. Recruitment proved to be a 
challenge due to a number of eligible participants living a substantial distance from the study 
location, rendering travel for pre- and post-testing unrealistic. Another limitation was our 
heterogeneous sample. Ideally, grouping participants based on lesion type or severity would allow 
for more precise and generalizable results. The advantages of a homogenous sample have been 
58 
 
previously demonstrated in children with Fontan circulation (4, 14, 19) and Tetralogy of Fallot 
(24). However, again due to the smaller population of children with CHD in our region, patients 
were grouped in order to increase the sample size. 
 
3.4.2 Methodology 
The addition of a CHD control group and a healthy CTL training group would have 
strengthened the results of our study by allowing further comparison of the effectiveness of the 
exercise intervention. To account for the potential influence of pre-study fitness, CHD and CTL 
participants should be matched for physical activity levels. Our study ran in two sections, beginning 
in two different seasons which may have also influenced pre-study fitness level. One group began 
the intervention in September after summer vacation, and the other began in January after school 
break.  Including direct measures of muscle mass and strength such as dual x-ray absorptiometry 
(DEXA) and/or maximal voluntary contraction knee extension exercise would help to corroborate 
the effectiveness of our intervention as well as inferences about TOI post-training. A direct measure 
of blood flow would also strengthen our study by providing an additional measurement of cardiac 
mechanisms of exercise tolerance. 
Our wide age range may also influence our results. The difficulty of obtaining and 
identifying peak data from young children due to short attention spans and poor motivation has 
been described previously (23). In the case of our participants younger than 10 years old, it was 
difficult to maintain maximal effort level and prevent the participant from stopping prematurely. 
There was also a learning curve in using the ergometer for the exercise test, as it was difficult for 
the younger participants to understand that they needed to maintain a consistent pedalling rate 
throughout the test. With varying participant ages, maturation and body size must also be taken 
into account when interpreting results. Armstrong et al. (2) classified boys and girls into appropriate 
maturity stages, and found that more mature boys and girls had significantly higher peak V̇O2 
values compared to those less mature, likely due to a greater muscle mass (2). Although we did not 
account for maturation, exploratory analysis using allometric scaling was used to partition out any 
influence body size or lean mass had on peak V̇O2 values.  Exploratory analysis did not reveal any 
differing trends between pre- and post-training in children with CHD and compared to CTL. It 
would be beneficial for future studies to incorporate a measure of maturity, and/or have more 
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stringent inclusion criteria for age, to reduce any potential influences maturity and body size may 
have.   
 
3.4.3 Exercise intervention 
An important factor to consider when designing an exercise program is whether the 
program can be generalized to all participating. It is well documented that individuals with low 
baseline fitness demonstrate the largest overall gains after a training program (3, 21), with the 
majority of improvement realized in the first 4-12 weeks of training (22). Exploratory analysis 
revealed children with CHD with a baseline peak V̇O2 less than 35 mL/kg/min tended to have an 
increase in peak V̇O2 of 2-3mL/kg/min post-training. In contrast, participants with a baseline peak 
V̇O2 greater than 35 mL/kg/min saw little to no improvement in peak V̇O2 scores. As our 
intervention was only 12 weeks long, it is possible that only those who had lower baseline fitness 
were able to gain more from our program. Interestingly, the majority of participants with low 
baseline fitness tended to have complex CHD lesions, whereas participants with higher baseline 
fitness tended to have simple CHD lesions. It has also been shown that patients in cardiac 
rehabilitation programming had greater gains in exercise tolerance when completing 36 or more 
exercise sessions (22). Our large inclusion criteria for compliance (60%, or 22/36 exercise sessions) 
may have masked any significant changes for those who completed all 36 sessions. Therefore, a 
larger sample size would allow more stringent inclusion criteria for compliance and may unmask 
further improvements in exercise tolerance. In the case of our least fit participant (baseline peak 
V̇O2 24 mL/kg/min) with a complex CHD lesion (Tetralogy of Fallot), completed 100% of 
prescribed exercise sessions. Post-training, this participant increased their peak V̇O2 to 28 
mL/kg/min. An increase of 4 mL/kg/min is significant, as every 1 mL/kg/min gain in V̇O2 has been 
shown to reduce cardiac mortality by 10% (10). Our data shows that not one size fits all when it 
comes to exercise prescription. Future work should consider baseline peak V̇O2 as an inclusion 
criterion, as well as more appropriate and specific programming to suit the needs of both low and 
high fit individuals with CHD and improve quality of life.  
Including more frequent check-ins with the participants may have helped to increase 
compliance and reduce drop out from the program. Specifically, being able to communicate 
directly with the children, instead of through their parents may have increased motivation. 
Although videos and detailed cues were given for each of the different exercises, a follow-along 
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video of the entire exercise session may have made it easier for children to complete sessions 
independent of parental help. It would also be helpful if children were able to complete the exercise 
sessions with others participating in the intervention, even if they live in a remote area. Tele-health 
is a popular emerging format that allows health care to be more accessible to those who live rurally 
and remotely. Particularly for this demographic, mobile-based physical activity monitoring may be 
the way of the future in chronic disease management programming. A potential way to bridge these 
gaps in program administration is the creation of an online/mobile application. Previous studies 
have shown the effectiveness of mobile physical activity monitoring in patients with COPD (12, 
25).  An app specific to our children’s needs might include secure instant messaging to help the 
children and the investigator communicate more frequently about questions or concerns regarding 
the program, as well as a video feature (similar to Facetime) to allow children to complete the 
exercise sessions together virtually. The application could provide easy access to exercise cues, 
follow along exercise videos, and could be expanded to include various education topics pertinent 
to children with CHD. Most importantly, a mobile-based program may help children with CHD 
feel a sense of community and support through regular interaction with others who have 
experienced similar physical and mental health challenges. In turn, this may positively influence 
children with CHD to be proactive about their health throughout their lifetime.    
 
3.5 Future Directions  
 Future studies should utilize a homogenous sample based on CHD lesion type, baseline 
fitness level and maturity. Inclusion of a non-training CHD group, as well as a training CTL group 
to better compare adaptations to a home-based exercise intervention and pinpoint peripheral 
limitations to exercise intolerance in children with CHD. Measures of peripheral mechanisms, such 
as TOI via NIRS, should continue to be used to directly measure microvascular adaptations. 
Improvements to our novel exercise intervention should be taken into consideration for future 
work, and subsequently be used to create a sustainable evidence-based exercise rehabilitation 
program for children with CHD.  
 
3.6 Conclusion 
The present study demonstrated for the first time a further decrease in exercise TOI after a 
12-week home-based exercise intervention, which may be due to improvements in O2 extraction 
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and utilization. Our program did not elicit changes in V̇O2 or HR, identifying a potential mismatch 
in central and peripheral training adaptations. These findings show that feasible and applicable 
exercise rehabilitation may be effective in improving exercise tolerance in children with CHD. The 
importance of this research area is highlighted by the lack of rehabilitation resources available for 
children and adults with CHD, and the increased risk of further chronic disease development later 
in life. It is imperative that steps are taken promptly to mitigate this gap in health promotion for 
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   PARTICIPANT INFORMATION AND PARENTAL CONSENT FORM  
 
A Pilot Health Intervention Study of Children with Congenital Heart Defects: CHAMPS – Children’s 
Healthy Heart Camp in Saskatchewan 
 
 
PRINCIPAL INVESTIGATOR:     
Dr. Marta Erlandson, College of Kinesiology      
Email: marta.erlandson@usask.ca    
Phone: 306-966-1071 
 
CO-PRINCIPAL INVESTIGATORS:  
Dr. Corey Tomczak, College of Kinesiology  Dr. Kristi Wright, University of Regina  
Email: corey.tomczak@usask.ca    Email: Kristi.wright@uregina.ca  
Phone: 306-966-1066     Phone: 306-585-4772 
  
 




Your child is invited to participate in this study because he/she is between the ages of 7-15 and has a 
clinical diagnosis of a congenital heart defect.  This study is looking at the physical and mental health of 
children with congenital heart defects compared to children without congenital heart defects.  The study is 
also examining a physical activity, heart health and psychological health intervention for children with 
congenital heart defects.  
 
Your child’s participation is voluntary. It is up to him/her and you to decide whether or not he/she wishes 
to take part. If your child wishes to participate, you will be asked to sign this form. If he/she does decide 
to take part in this study, he/she is still free to withdraw at any time and without giving any reasons for the 
decision. 
 
If your child does not wish to participate in the study, it will not affect his/her medical care in any way. 
Pediatric cardiologists and clinic staff will not know whether your child chooses to participate or not.  
 
Please take time to read the following information carefully. You can ask the researcher to explain any 
words or information that you do not clearly understand. You may ask as many questions as you need. 
Please feel free to discuss this with your family, friends or family physician before you decide. 
 
WHO IS CONDUCTING THE STUDY?  
The study is led by Dr. Marta Erlandson, a faculty member in the College of Kinesiology at the University 
of Saskatchewan. This research is funded by the Children’s Hospital Foundation of Saskatchewan. Neither 






WHY IS THIS STUDY BEING DONE? 
Congenital heart defects are the world’s leading type of birth defect. Children with congenital heart 
defects have higher rates of physical inactivity and obesity compared to healthy peers. This may mean that 
children with congenital heart defects are more likely to have chronic conditions such as heart disease and 
poor bone health (osteoporosis) later in life. It has also been found that children with congenital heart 
defects have high levels of anxiety around physical activity participation. While we know that children 
with congenital heart defects have higher rates of obesity little is known about their muscle, bone and 
heart health. This study will look at important aspects of the physical and mental health of children with 
congenital heart defects.   
 
Past research has highlighted the need for programming for children with congenital heart defects that 
involves healthy lifestyle counseling and physical activity participation. Parents of children with 
congenital heart defects have reported having minimal resources for knowing how to establish safe levels 
of physical activity for their children. Currently, there is no such program in Saskatchewan or Canada to 
help parents and children with congenital heart defects. This study will be the first step in developing a 
physical activity, heart health and psychological health program for children with congenital heart defects 
and their families.   
 
WHO CAN PARTICIPATE IN THE STUDY?  
Your child is eligible to participate in this study if he/she is aged 7-15 years and has been cleared to 
participate by the pediatric cardiology team at the Royal University Hospital (RUH). Your child is not 
eligible if he/she: (1) had cardiac surgery in the last six months; (2) has cyanotic congenital heart disease; 
(3) has significant valve disease; (4) has any physical condition limiting physical activity; and/or (5) is 
unable to complete all the questionnaires.  
 
WHAT DOES THE STUDY INVOLVE? 
 
The study involves two or three parts.  
 
Part 1 involves a single visit to the Physical Activity Complex (PAC) at the University of Saskatchewan in 
June, July or August. This visit will take approximately four hours. During this visit, your child will be 
asked to complete a form with his/her personal information (such as name, telephone number, and date of 
birth) and will also be asked to complete, with your assistance if needed, questionnaires about his/her 
general health history, physical activity, psychological well-being (health related anxiety questionnaires, 
mood (mood measurements will assess potential depressive symptoms of you child), and body 
appreciation), and dietary intake (24-hour recall). Self-reported parental heights and weights will also be 
recorded. We will measure the following: 
• Your child’s height, sitting height, weight, waist circumference, and limb length. 
• Your child’s body composition using DXA (dual energy x-ray absorptiometry). DXA is a scan 
that is done while your child lies on his/her back on what looks like a padded x-ray table. We will 
measure his/her total body, hip and spine. The scan assesses total body bone, muscle and fat 
tissues. The scans take approximately 10 minutes and will expose your child to a minimal amount 
of radiation (less than 5µSV).  
• Your child’s bone shape and strength using a peripheral quantitative computed tomography 
(pQCT) and a high resolution peripheral quantitative computed tomography (HRpQCT) scan of 
his/her non-dominant arm and lower leg (each scan takes about 2 minutes). For these scans your 
child will sit on a padded chair with his/her arm or leg resting on a support. All tests are painless 
and non-invasive. pQCT and HRpQCT are forms of x-ray and therefore do emit a small amount of 
radiation. The total radiation for all measurements (DXA, pQCT, and HRpQCT) is less than 
6µSV; this is comparable to the amount of background radiation a person receives in five days 
from naturally-occurring sources in Saskatchewan. For reference a cross-country flight could 
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expose a person to about 30µSV of radiation (http://www.hc-sc.gc.ca/hc-ps/ed-
ud/respond/nuclea/measurements-mesures-eng.php).  All scans will be administered by trained 
and certified personnel.  
• Your  child’s heart health using the following seven tests:    
1. Three small stickers connected with a wire to our computer will be attached to your child’s 
shoulders and stomach. The information from the stickers will tell us about the activity of your 
child’s heart. The stickers are gentle on the skin and are the same ones that the hospital uses 
when it measures your child’s heart activity. We will measure your child’s heart activity while 
he/she lies on his/her back for ten minutes. This test does not cause any discomfort and there 
are no health risks associated with it.  
2. The health of your child’s blood vessels will be measured using a special machine at the same 
time as the first test. The machine uses a special pen that is placed on the skin to give a picture 
of your child’s blood pressure. Your child will need to lie still for about 5 minutes. This test 
does not cause any discomfort and there are no health risks associated with it.  
3. Your child’s nerves and blood vessels will tested by having your child squeeze a hand gripper 
for two minutes. After this we will inflate a blood pressure cuff and will keep it inflated for two 
to three minutes. While the cuff is inflated we will monitor your child’s blood pressure. The 
handgrip test will be repeated without inflating a blood pressure cuff. During both handgrip 
tests we will measure blood pressure. This test can cause a slight tingling sensation in the arm 
from the blood pressure cuff. The sensation goes away when the cuff pressure is released. 
4. Your child’s fitness will be tested with a low-intensity walk test to see how far he/she can walk 
in 6 minutes. Your child will walk at his/her own speed back and forth in a hallway for 6 
minutes. We will measure your child’s heart rate and blood pressure before and after the walk 
test. The walk test is safe for those with heart problems because it is of low intensity and your 
child chooses how fast or slow he/she walks. We will closely monitor your child during the 
walk test. 
5. Your child’s fitness will also be testing using a stationary exercise bike while they breathe 
through a special mouthpiece that measures how much oxygen they use during exercise. This 
test will take 5 to 10 minutes. We will measure your child’s blood pressure and monitor their 
breathing and heart activity.  This test is also safe for those with heart problems in whom their 
condition is stable. As an extra precaution, a pediatric resident will monitor this test. This test 
will take a total of 30 minutes. 
6. Your child’s heart structure and function will be assessed using cardiac ultrasound. This 
assessment will entail your child lying restfully on their side for 30 minutes. During this time, 
Dr. Timothy Bradley (Pediatric Cardiologist) will use a special ultrasound machine to take 
pictures of your child’s heart. The assessment will entail performing a series of images by 
placing a probe in different positions over your child’s chest. This assessment is very safe, low 
risk, is entirely non-invasive, and places no stress on your child. This test will take a total of 30 
minutes. 
7. Your child’s blood vessel function will also be measured using vascular ultrasound. This 
assessment will be performed while your child is doing the handgrip exercise test described in 
#3 above. The assessment will entail placing a probe over your child’s arm. This assessment is 
very safe, low risk, is entirely non-invasive, and places no stress on your child. This test will 
not add any time to your child’s session. 
• Your child’s ability to utilize oxygen during exercise will be measured using near-infrared 
spectroscopy (NIRS). NIRS uses near-infrared light to provide a measurement of the amount of 
oxygen used in the muscle. We will place a small NIRS probe on the thigh and wrap it in a cloth 
to block out room light. NIRS is non-invasive and places no stress on your child. There are no 




After the visit to the University, your child will be asked to wear an accelerometer for 7 consecutive days. 
An accelerometer is a type of motion sensor that measures your child’s physical activity. It is a small 
device that will be worn around your child’s waist on an elastic belt. He/she will be asked to put it on first 
thing in the morning and wear it all day except when bathing, swimming or playing contact sports.  
During your visit at the University, you will be provided with an addressed and stamped envelope to 
return the accelerometer after the seven days of wear.  
Your child will also be asked to recall dietary intake in the past 24 hours on three occasions, a weekday 
and a weekend day prior to the Camp, and a weekday at the Camp, using an online tool called the ASA24-
Canada-2016. Parental assistance may be required for younger children. Orientation, username and 
password will be provided by the researcher at your visit to the University.  
    
Part 2 of the study involves a day-camp. This portion of the study will take place at the College of 
Kinesiology, University of Saskatchewan from August 10-14th, 2015. The program will run from 9am-
5pm and will consist of three parts: (1) physical activity promotion and participation; (2) heart health and 
health behavior; and (3) psychological well-being. Your child will be grouped based on age: younger (7-
12) and older (13-15) and take part in activities that are age-appropriate. The physical activity portion will 
be of low to moderate intensity and comply with established international recommendations for children 
with congenital heart defects. Example activities include: swimming and ball and racquet sports. Your 
child will wear an accelerometer for the week long camp to assess the amount of physical activity. Your 
child will also engage in sessions on healthy eating, heart health, and how to detect his/her physical 
limitations (heart health and health behavior part). The psychological wellbeing part will focus on 
teaching your child healthy psychosocial coping mechanisms with a special emphasis on understanding 
and coping with anxiety related to physical activity participation. The program will incorporate many 
important health aspects but will do so in a fun, summer camp style of programming. During the Camp we 
will also assess your child’s physical literacy; their ability to run, jump, throw and catch and have you fill 
out a questionnaire about your perceptions of their ability to move confidently. To assess your and your 
child’s satisfaction with the program we will ask both of you to fill out a short questionnaire when you 
pick your child up on the last day. At the end of the sessions, your child will be asked to complete the 
measures of psychological well-being once again, in the presence of a child psychologist. After the 
program your child will be mailed an accelerometer to once again wear for seven consecutive days along 
with an addressed and stamped envelope to return it after the seven days.  
 
Part 3 of this study will include a small sample of parents and children so you may or may not be invited 
to participate in a focus group held at the Social Science Research Lab at the University of Saskatchewan 
in late August or early September. The focus group will look at satisfaction with the camp, what 
participants liked and would like to see changed in future programming.  
 
Part 4 of this study will include home-based exercise sessions that last 20-30 minutes 3 times per week for 
12 weeks, in addition to biweekly psychology and physical activity sessions led by researchers at the 
University of Saskatchewan. The researcher will conduct weekly follow ups by phone or in person to aid 
in adherence to the program, as well as assistance with program sessions. Detailed instructions for 
completing each session will be given to participants.  
The pediatric cardiologist will be consulted prior to beginning the the home-based program to ensure there 
are no restrictions for exercise for your child.  
Home exercise sessions will include both light aerobic and strength exercise components. Briefly, each 
session will include 20 minutes aerobic exercises in the form of brisk walking or stationary bike riding (at 
the Physical Activity Complex when attending bi-weekly psychology sessions). Strength exercise will 
comprise of activities that utilize participant’s own body weight (no equipment is required). Example 
exercises include squatting up and down, lunges (stepping forward with one leg), stair stepping (up 2 
steps, down 2 steps), basic push ups, calf raises (standing on tip toes, return to flat footed position). Over 
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the course of 12 weeks these exercises will be increased for the number of repetitions completed and will 
take no longer than 10 minutes. Total exercise time for a session will be at most 30 minutes.  
The volume and type of physical activity performed is the same as what is commonly encountered during 
normal play activities and during physical education programming in school settings. We highlight that a 
pediatric cardiologist will confirm exercise suitability for your child before the program begins. 
 
If you consent, we may take photographs of your child during the study that would be used only for 
research and/or teaching presentations. These photographs would be de-identified so your child’s face 
would not be recognizable.  
 
WHAT ARE THE BENEFITS OF PARTICIPATING IN THIS STUDY?  
There may be no direct benefit to your child from participating in this study. Your child will get to 
participate in the week long program aimed to teach your child how to detect his/her physical limitations 
with regard to physical activity and provide him/her with the tools cope with health related physical 
activity anxiety and hopefully empower him/her to be more physically active. It is hoped that the 
information gained from this study can be used in the future to create a sustainable program for children 
with congenital heart defects.  
 
ARE THERE POSSIBLE RISKS AND DISCOMFORTS? 
The risks of participating are minimal. The fitness test on a stationary bike will assess your child’s 
exercise capacity. During this test, your child may feel a few minutes of physical fatigue that comes with 
exercise. They also may experience some leg soreness as a consequence of this test, but this should 
disappear within 2 days. This stationary bike test is safe and the intensity of how hard your child exercises 
is determined by your child. As an extra precaution, a pediatric resident will supervise the stationary bike 
test. As stated above, the bone measures (DXA, pQCT and HRpQCT) will expose your child to a minimal 
amount of radiation. These tests are very low risk; the total radiation dose for each study visit is less than 
half of that of a standard chest x-ray. As with any physical activity there is the potential of physical injury 
or discomfort. Your child may experience sore muscles after the six minute walk test. If your child 
experiences soreness it will not last very long. We have taken every precaution to ensure all physical 
activity during the camp will be safe for your child and a pediatric resident will be at the weeklong camp 
in the unlikely event that medical attention is needed. The depressive symptoms questionnaire will ask 
questions about your child’s feelings and ideas and this may be a sensitive topic for some children. We 
will show you the questionnaire prior to your child completing it, in order to allow you to pre-screen your 
comfort level with the sensitive questions that will be posed to your child. You can choose to have your 
child not complete this questionnaires or specific questions within the questionnaire. If you choose this, 
your child can still participate in other aspects of the study.   
    
WHAT HAPPENS IF I DECIDE TO WITHDRAW? 
Your child’s participation in this research is voluntary. He/she may withdraw from this study at any time. 
You do not have to provide a reason. Your child’s relationship with the department of pediatric cardiology 
will not be affected and pediatric cardiologists and clinic staff will not be informed. 
 
If your child chooses to enter the study and then decides to withdraw later, all data collected about him/her 
during his/her enrolment will be retained for analysis.  
 
WHAT WILL THE STUDY COST ME? 
You will not be charged for any research-related procedures and your child will not be paid for 
participating in this study. Your parking costs at the University for the Part 1 visit will be covered.  
 
WHAT HAPPENS IF SOMETHING GOES WRONG?  
 71 
In the unlikely event that your child is injured while participating in this research, appropriate medical 
care will be provided at no cost to you. By signing this document, you and your child do not waive any of 
your legal rights.   
 
WILL MY TAKING PART IN THIS STUDY BE KEPT CONFIDENTIAL? 
Your child’s confidentiality will be respected.  No information that discloses your child’s identity will be 
released or published without your specific consent to the disclosure.  The information collected in this 
study will be stored in the locked office of the PI, Dr. Marta Erlandson. The results of this study may be 
presented in a scientific meeting or published, but your child’s identity will not be disclosed. If you 
consent we may use de-identified photographs of your child for the purpose of research and/or teaching 
presentations.   
 
 
WHO DO I CONTACT IF I HAVE QUESTIONS ABOUT THE STUDY? 
If you have any questions or desire further information about this study before or during participation, you 
can contact Marta Erlandson by phone at 306-966-1071 or by email at marta.erlandson@usask.ca. 
 
If you have any concerns about your child’s rights as a research participant and/or your experiences while 
participating in this study, contact the Chair of the University of Saskatchewan Research Ethics Board, at 
306-966-2975(out of town calls 1-888-966-2975). The Research Ethics Board is a group of individuals 
(scientists, physicians, ethicists, lawyers and members of the community) that provide an independent 
review of human research studies. This study has been reviewed and approved on ethical grounds by the 







A Pilot Health Intervention Study of Children with Congenital Heart Defect: CHAMPS – Children’s 
Healthy Heart Camp in Saskatchewan 
 
 
o I have read (or someone has read to me) the information in this consent form. 
o I understand the purpose and procedures and the possible risks and benefits of the study.  
o I was given sufficient time to think about it. 
o I had the opportunity to ask questions and have received satisfactory answers. 
o I understand that my child is free to withdraw from this study at any time for any reason.  
o I have been informed that there is no guarantee that this study will provide any benefits to my child.  
o I give permission to the use and disclosure of my child’s de-identified information collected for the 
research purposes described in this form. 
o I understand that by signing this document I do not waive any of my or my child’s legal rights. 
o I understand I will be given a signed copy of this consent form. 
 




I agree to allow my child to participate in this study: 
 
 
Printed name of person providing consent: ______________________________ 
Signature of Consenting Parent:   Date __________ 
 
 
Printed name of person obtaining consent:    ________________ 
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A Pilot Health Intervention Study of Children with Congenital Heart Defects: CHAMPS – Children’s 
Healthy Heart Camp in Saskatchewan 
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Your child is being invited to participate in this study because he/she is between the ages of 7-17 and is a 
healthy child with no history of heart problems. This study is looking at the physical and mental health of 
children with congenital heart defects compared to healthy children.  
 
Your child’s participation is voluntary. It is up to him/her and you to decide whether or not he/she wishes 
to take part. If your child wishes to participate, you will be asked to sign this form. If he/she does decide 
to take part in this study, he/she is still free to withdraw at any time and without giving any reasons for the 
decision. 
 
Please take time to read the following information carefully. You can ask the researcher to explain any 
words or information that you do not clearly understand. You may ask as many questions as you need. 
Please feel free to discuss this with your family, friends or family physician before you decide. 
 
WHO IS CONDUCTING THE STUDY?  
The study is led by Dr. Marta Erlandson, a faculty member in the College of Kinesiology at the University 
of Saskatchewan. This research is funded by the Children’s Hospital Foundation of Saskatchewan. Neither 
the University nor any of the investigators will receive any direct financial benefit for conducting this 
study.  
 
WHY IS THIS STUDY BEING DONE? 
Congenital heart defects are the world’s leading type of birth defect. Children with congenital heart 
defects have higher rates of physical inactivity and obesity compared to healthy peers. This may mean that 
children with congenital heart defects are more likely to have chronic conditions such as heart disease and 
poor bone health (osteoporosis) later in life. It has also been found that children with congenital heart 
defects have high levels of anxiety around physical activity participation. While we know that children 
with congenital heart defects have higher rates of obesity little is known about their muscle, bone and 
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heart health. This study will look at important aspects of the physical and mental health of children with 
congenital heart defects compared to healthy peers.   
 
WHO CAN PARTICIPATE IN THE STUDY?  
Your child is eligible to participate in this study if he/she is aged 7-17 years and of good health. Your 
child is not eligible if he/she has any type of heart issues or other health condition that affects his/her 
ability to perform physical activity.   
 
WHAT DOES THE STUDY INVOLVE? 
 
If your child decides to participate in the study it will involve a single visit to the Physical Activity 
Complex (PAC) at the University of Saskatchewan. The visit will take approximately four hours.  Your 
child will be requested to complete a form with his/her personal information (such as name, telephone 
number, and date of birth) and will also be asked to complete, with your assistance if needed, 
questionnaires regarding his/her general health history, physical activity, psychological well-being (health 
related anxiety and body appreciation questionnaires) and dietary intake (24-hour recall). Self-reported 
parental heights and weights will also be recorded. We will measure the following:  
1. Your child’s height, sitting height, weight, waist circumference, and limb length.  
2. Your child’s body composition using DXA (dual energy x-ray absorptiometry). DXA is a scan 
that is done while your child lies on his/her back on what looks like a padded x-ray table. We will 
measure his/her total body, hip and spine. The scan assesses total body bone, muscle and fat 
tissues. The scans take approximately 10 minutes and will expose your child to a minimal amount 
of radiation (less than 5µSV). 
3. Your child’s bone shape and strength using a peripheral quantitative computed tomography 
(pQCT) and a high resolution peripheral quantitative computed tomography (HRpQCT) scan of 
his/her non-dominant forearm and lower leg (each scan takes about 2 minutes). For these scans 
your child will sit on a padded chair with his/her arm or leg resting on a support. All tests are 
painless and non-invasive. pQCT and HRpQCT are forms of x-ray and therefore do emit  a small 
amount of radiation. The total radiation for all measurements (DXA, pQCT, and HRpQCT) is less 
than 6µSV; this is comparable to the amount of background radiation a person receives in five 
days from naturally-occurring sources in Saskatchewan. For reference a cross-country flight could 
expose a person to about 30µSV of radiation (http://www.hc-sc.gc.ca/hc-ps/ed-
ud/respond/nuclea/measurements-mesures-eng.php).  All scans will be administered by trained 
and certified personnel.     
4. Your child’s heart health using the seven following tests:  
A) Three small stickers will be attached to your child’s shoulders and stomach. The stickers are 
connected with a wire to our computer and will tell us about your child’s heartbeat. The stickers 
are gentle on the skin. They are the same stickers that the hospital uses when it measures heart 
activity. The stickers are thrown away after we are done the measure. With the stickers we will 
measure your child’s heart activity while he/she lies on his/her back for ten minutes. This test does 
not cause any discomfort and there are no health risks associated with this test.  
B) The second test will measure your child’s blood vessels. This will be done using a special 
machine at the same time as the first test. The machine uses a special pen that is placed on the skin 
to give a picture of your child’s blood pressure. The test will tell us about the health of the blood 
vessels and requires your child to lie still for about 5 minutes. This test does not cause any 
discomfort and there are no health risks associated with it.  
C) The third test will measure how your child’s nerves and blood vessels work. This will be done 
by having your child squeeze a hand gripper for two minutes. After this we will inflate a blood 
pressure cuff and will keep it inflated for two to three minutes. While the cuff is inflated we will 
monitor your child’s blood pressure. The handgrip test will be repeated without inflating a blood 
pressure cuff. During both handgrip tests we will measure blood pressure. This test can cause a 
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slight tingling sensation in the arm from the blood pressure cuff. The sensation goes away when 
the cuff pressure is released.  
D) Your child’s fitness will be tested with a low-intensity walk test. We want to know how far 
your child can walk in 6 minutes. Your child will walk at his/her own speed back and forth in a 
hallway for 6 minutes. We will measure your child’s heart rate and blood pressure before and after 
the walk test. The walk test is safe for most individuals because it is of low intensity and your 
child chooses how fast or slow he/she walks. We will closely monitor your child during the walk 
test and he/she will choose how fast or slow he/she walks. 
E) Your child’s fitness will also be testing using a stationary exercise bike while they breathe 
through a special mouthpiece that measures how much oxygen they use during exercise. This test 
will take 5 to 10 minutes. We will measure your child’s blood pressure and monitor their 
breathing and heart activity.  This test is also safe for the general population. This test will take a 
total of 30 minutes.  
F) Your child’s heart structure and function will be assessed using cardiac ultrasound. This 
assessment will entail your child lying restfully on their side for 30 minutes. During this time, Dr. 
Timothy Bradley (Pediatric Cardiologist) will use a special ultrasound machine to take pictures of 
your child’s heart. The assessment will entail performing a series of images by placing a probe in 
different positions over your child’s chest. This assessment is very safe, low risk, is entirely non-
invasive, and places no stress on your child. This test will take a total of 30 minutes. 
G) Your child’s blood vessel function will also be measured using vascular ultrasound. This 
assessment will be performed while your child is doing the handgrip exercise test described in #3 
above. The assessment will entail placing a probe over your child’s arm. This assessment is very 
safe, low risk, is entirely non-invasive, and places no stress on your child. This test will not add 
any time to your child’s session. 
5. Your child’s ability to utilize oxygen during exercise using near-infrared spectroscopy (NIRS). 
NIRS uses near-infrared light to provide a measurement of the amount of oxygen used in the 
muscle. We will place a small NIRS probe on the thigh and wrap it in a cloth to block out room 
light. NIRS is non-invasive and places no stress on your child. There are no health risks associated 
with this test.  
 
 
After the visit to the University, your child will also be asked to wear an accelerometer for 7 consecutive 
days. An accelerometer is a type of motion sensor that measures your child’s physical activity.  It is a 
small device that will be worn around your child’s waist on an elastic belt. He/she will be asked to put it 
on first thing in the morning and wear it all day except when bathing, swimming or playing contact sports.  
During your visit at the University you will be provided with an addressed and stamped envelope to return 
the accelerometer after the seven days of wear.  
 
Your child will also be asked to recall dietary intake in the past 24 hours on three occasions, at the initial 
appointment and independently for a weekend and weekday. This will be done using an online tool called 
the ASA24-Canada-2016. Parental assistance may be required for younger children. Orientation, 
username and password will be provided by the researcher at your visit to the University.  
 
WHAT ARE THE BENEFITS OF PARTICIPATING IN THIS STUDY?  
There may be no direct benefit to your child from participating in this study. It is hoped that the 
information gained from this study will positively affect the health of children with congenital heart 
defects and contribute to the development of a program to promote physical activity and healthy lifestyle 
counseling for this population.  
 
ARE THERE POSSIBLE RISKS AND DISCOMFORTS? 
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The risks of participating are the minimal. The fitness test on a stationary bike will assess your child’s 
exercise capacity. During this test, your child may feel a few minutes of physical fatigue that comes with 
exercise. They also may experience some leg soreness as a consequence of this test, but this should 
disappear within 2 days. This stationary bike test is safe and the intensity of how hard your child exercises 
is determined by your child. As stated above the bone measures (DXA, pQCT and HRpQCT) will expose 
your child to a minimal amount of radiation. The tests are very low risk; the total radiation dose for the 
study is less than half of that of a standard chest x-ray. As with any physical activity there is a slight risk 
that your child may experience sore muscles after the six minute walk test. If your child experiences 
soreness it will not last very long.  
    
WHAT HAPPENS IF I DECIDE TO WITHDRAW? 
Your child’s participation in this research is voluntary. He/she may withdraw from this study at any time. 
You do not have to provide a reason.  
 
If your child chooses to enter the study and then decides to withdraw later, all data collected about him/her 
during his/her enrolment will be retained for analysis.  
 
WHAT WILL THE STUDY COST ME? 
You will not be charged for any research-related procedures and your child will not be paid for 
participating in this study. Your parking costs at the University will be covered.  
 
WHAT HAPPENS IF SOMETHING GOES WRONG?  
In the unlikely event that your child is injured while participating in this research, appropriate medical 
care will be provided at no cost to you. By signing this document, you and your child do not waive any of 
your legal rights.   
 
WILL MY TAKING PART IN THIS STUDY BE KEPT CONFIDENTIAL? 
Your child’s confidentiality will be respected.  No information that discloses your child’s identity will be 
released or published without your specific consent to the disclosure.  The results of this study may be 
presented in a scientific meeting or published, but your child’s identity will not be disclosed.  
 
WHO DO I CONTACT IF I HAVE QUESTIONS ABOUT THE STUDY? 
If you have any questions or desire further information about this study before or during participation, you 
can contact Marta Erlandson by phone at 306-966-1071 or by email at marta.erlandson@usask.ca. 
 
If you have any concerns about your child’s rights as a research participant and/or your experiences while 
participating in this study, contact the Chair of the University of Saskatchewan Research Ethics Board, at 
306-966-2975(out of town calls 1-888-966-2975). The Research Ethics Board is a group of individuals 
(scientists, physicians, ethicists, lawyers and members of the community) that provide an independent 
review of human research studies. This study has been reviewed and approved on ethical grounds by the 














A Pilot Health Intervention Study of Children with Congenital Heart Defects: CHAMPS – Children’s 
Healthy Heart Camp in Saskatchewan 
 
 
o I have read (or someone has read to me) the information in this consent form. 
o I understand the purpose and procedures and the possible risks and benefits of the study.  
o I was given sufficient time to think about it. 
o I had the opportunity to ask questions and have received satisfactory answers. 
o I understand that my child is free to withdraw from this study at any time for any reason.  
o I have been informed that there is no guarantee that this study will provide any benefits to my child.  
o I give permission to the use and disclosure of my child’s de-identified information collected for the 
research purposes described in this form. 
o I understand that by signing this document I do not waive any of my or my child’s legal rights. 
o I understand I will be given a signed copy of this consent form. 
 
 
I agree to allow my child to participate in this study: 
 
 
Printed name of person providing consent: ______________________________ 
Signature of Consenting Parent:   Date __________ 
 
 
Printed name of person obtaining consent:    ________________ 














































PARTICIPANT INFORMATION AND ASSENT FORM 
 
A Pilot Health Intervention Study of Children with Congenital Heart Defects: CHAMPS – Children’s 
Healthy Heart Camp in Saskatchewan 
 
Researchers:     
Dr. Marta Erlandson, College of Kinesiology    Dr. Kristi Wright, University of Regina   
Email: marta.erlandson@usask.ca   Email: Kristi.wright@uregina.ca 
Phone: 306-966-1071     Phone: 306-585-4772 
 
Dr. Corey Tomczak, College of Kinesiology     
Email: corey.tomczak@usask.ca      





This form may use words you do not understand. Please ask the person explaining the study to explain any 
words or information that you do not clearly understand. 
You are being asked to take part in a research study because when you were born your heart didn’t work 
exactly as it was supposed to. The study will help us find out more about your muscle, bone and heart health. 
It will also help us learn how you feel about participating in physical activity.  
 
A research study is something like a science project in school. The people who are doing this study want to 
learn something new about children who are born with heart problems like the one you have and how you 
feel about physical activity and exercise. When the study is over, they will see what kinds of activities are 
the best for you to participate in. At the end of the study the researchers want you to feel more comfortable 
and confident in participating in different physical activities at school and with your friends.  
 
What happens in this Study?  
The study will be done at the College of Kinesiology on the University Campus. You will come to the 
university for two times. The first time you come the researchers will ask you to fill in some questionnaires 
which your parents can help you with if you would like. The researchers will then measure how tall you are, 
how much you weigh and how long your lower arm and leg are. The researchers will measure your bones 
using three special imaging machines. One of the machines will take a picture of your whole body while 
you lay on a bed and the other two will take a picture of your arm and leg bones. The researchers will also 
measure your heart and the veins and arteries that carry your blood around your body and to your heart using 
four different tests. For the first test they will put stickers on your shoulders and stomach while you lay on 
a bed. The stickers will read what your heart is doing, you will not feel anything. For the second test you 
will have to lie still while the researcher measures your blood vessels with a special pen. Again you will not 
feel anything while they take this measurement. For the third test, you will squeeze your hand on a special 
machine for two minutes while the researcher measures your blood pressure. The researcher will also take 
a picture of your blood vessels. For the fourth test you will be asked to walk at whatever speed you would 
like for 6 minutes. For the fifth test you will be asked to pedal on a bike your breathing is measured. For the 
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sixth test you will be asked to lie still while a researcher takes pictures of your heart. For the last test, you 
will be asked to pedal on a bike while special stickers measure how your muscles work during exercise. 
You will not feel anything. After finishing these activities the researchers will give you a small device 
(motion sensor) that you will wear on your hip for seven days. 
 
For the second part of the study you will come back to the College of Kinesiology. This part of the study 
will be similar to a summer camp. Each day you will participate in different physical activities like 
swimming and playing in the gym. You will also learn skills to help you feel more comfortable about 
participating in physical activity as well as healthy eating, heart health, and emotional health.   
 
You will be asked to wear the small motion sensor on your hip for seven days again after the camp has 
finished.  
 
For the third part of the study, you will be asked to complete exercises at home with the help of your parents 
or camp counsellors. They will be similar to exercises you have done in gym class and at CHAMPS camp. 
You will also come back to the College of Kinesiology and participate in activities like swimming and rock 
climbing. You will also learn about your emotional health.  
 
If you agree the researchers may also take pictures of you while are you participating in the study. The 
pictures would be used only for research or teaching presentations and your face would be blacked out so 
no one would be able to recognize you.  
 
You do not have to agree to be in this study.  
 
Withdrawal from Study 
You do not have to be in this study and you can stop being in this study at any time.  If you say yes now, 
but change your mind later, you can say no and that will be okay. If you decide not to participate, no one 














I have read this paper or have had it read to me.  I understand what I have to do in this study and I 




Child’s Name (Print) 
 
 
______________________________________________  _______________________ 
Child’s Signature     Date 
 
 






Check which applies (to be completed by person administering assent): 
  The subject is capable of reading and understanding the assent form and has signed above as 
documentation of assent to take part in this study. 
 
  The subject is not capable of reading the assent form, however, the information was explained 




Name of Person Administering Assent (Print) 
_______________________________________________ _______________________ 











































PARTICIPANT INFORMATION AND ASSENT FORM 
 
A Pilot Health Intervention Study of Children with Congenital Heart Defects: CHAMPS – Children’s 
Healthy Heart Camp in Saskatchewan 
 
Researchers:     
Dr. Marta Erlandson, College of Kinesiology    Dr. Kristi Wright, University of Regina   
Email: marta.erlandson@usask.ca   Email: Kristi.wright@uregina.ca 
Phone: 306-966-1071     Phone: 306-585-4772 
 
Dr. Corey Tomczak, College of Kinesiology     
Email: corey.tomczak@usask.ca       





This form may use words you do not understand. Please ask the person explaining the study to explain any 
words or information that you do not clearly understand. 
You are being asked to take part in a research study because you are a healthy person. The study will help 
us find out more about your muscle, bone and heart health.  
 
A research study is something like a science project in school. The people who are doing this study want to 
learn something new about children who are born with heart problems. When the study is over, they will 
see how muscle, bone and heart health is different in children with heart problems compared to healthy 
children.  
 
What happens in this Study?  
The study will be done at the College of Kinesiology on the University Campus. When you come in the 
researchers will ask you to fill in some questionnaires which your parents can help you with if you would 
like. The researchers will then measure how tall you are, how much you weigh and how long your lower 
arm and leg are. The researchers will measure your bones using three special imaging machines. One of the 
machines will take a picture of your whole body while you lay on a bed and the other two will take a picture 
of your arm and leg bones. The researchers will also measure your heart and the veins and arteries that carry 
your blood around your body and to your heart using six different tests. For the first test they will put stickers 
on your shoulders and stomach while you lay on a bed. The stickers will read what your heart is doing, you 
will not feel anything. For the second test you will have to lie still while the researcher measures your blood 
vessels with a special pen. Again you will not feel anything while they take the measurement. For the third 
test, you will squeeze your hand on a special machine for two minutes while the researchers measure your 
blood pressure. The researcher will also take pictures of your blood vessels. For the forth test you will be 
asked to walk at whatever speed you would like for 6 minutes. For the fifth test you will be asked to pedal 
on a bike your breathing is measured. For the sixth test you will be asked to lie still while a researcher takes 
pictures of your heart. For the last test, you will be asked to pedal on a bike while special stickers on your 
leg measure how your muscles work during exercise. You will not feel anything. After finishing these 
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activities the researchers will give you a small device (motion sensor) that you will wear on your hip for 
seven days. You will also be asked to remember what you ate over three different days and enter it into an 
online tracker. Your parents can help you fill this out. You will be asked to do this on two weekdays and 
one weekend day.  
 
You do not have to agree to be in this study.  
 
 
Withdrawal from Study 
You do not have to be in this study and you can stop being in this study at any time.  If you say yes now, 
but change your mind later, you can say no and that will be okay. If you decide not to participate, no one 
will be upset or disappointed.  
 
ASSENT 
I have read this paper or have had it read to me.  I understand what I have to do in this study and I 




Child’s Name (Print) 
 
 
______________________________________________  _______________________ 




       
Check which applies (to be completed by person administering assent): 
  The subject is capable of reading and understanding the assent form and has signed above as 
documentation of assent to take part in this study. 
 
  The subject is not capable of reading the assent form, however, the information was explained 
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PHASE 1: 4 weeks, 3 times per week, 20-30 minute workouts 
 
 
What is the Rating of Perceived Exertion (RPE) Scale? 
- The RPE scale is used to measure the intensity of your exercise. The RPE scale 
scores how hard something feels to you from 0 – 10. 
- “0” is no exertion / difficulty 
- “10” is maximal effort / difficulty  
- The RPE scale below provides phrases used to rate how easy or difficult you 
find an activity.  
 
 
**Please ensure you or your child records the 
RPE value for each exercise day** 
 
 
How do I make an exercise feel harder?  
(if your RPE is less than 4 – you need to make your RPE between 4 and 6!) 
 
- Try doing the exercise slower 
o Count one-Mississippi, two-Mississippi, 3- Mississippi as you do your 
exercise (such as your squat)  
- Do extra reps  
o Do 12-15 reps instead of 10 
- If the exercise is timed, do the exercise for longer 
o Do 30 seconds instead of 20 seconds 
o walk for 15 minutes instead of 10 minutes 
- Reduce the amount of time of rest in between exercises!  
o Instead of 30 seconds, only wait 15 seconds to begin the exercise again.  
o Or, instead of 2 minutes, only wait 1 minute to begin the exercise again.  
 
 
To view entire CHAMPS 12 week program exercises, follow this link: 
https://drive.google.com/open?id=1eSUVcjXiJuoDLyYccohMWWu15H4AkVSo 
 
Be sure to review your exercise cues for each exercise! These are important so you don’t 
get hurt.  
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DAY 1: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 1 program twice through. You will be doing 
exercises that target your lower body.  
 
When you exercise, you want to exercise at an RPE intensity of 4-6  
 
 
**Remember to mark your workout on your workout calendar with a sticker, 
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DAY 1 – WARM UP & STRETCH  
1. Go for a 10-minute brisk walk or 10-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 8 times. Rest for 1 minute. Then go up and down 
your stairs 8 times again.  
OR: 
  
Alternate Warm Up 
1. 50 jumping jacks  
2. 20 high knees 
3. 50 jumping jacks  
4. 20 butt kicks 
5. 50 jumping jacks  
6. 20 high knees  





2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 1 EXERCISE #1 – SQUATS 
 
STEP 1 – Do 10 squats. RPE = 4-6.  
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 squats.  

























1. Feet shoulder width apart, or slightly wider than shoulder width apart  
2. Stick your butt out, and lower your body as if you were sitting in a chair  
3. Make sure your knees DO NOT pass your toes.  
1. If they do, try sticking your butt out more (so you aren’t leaning too far forward) 
or do not go as low into your squat position  
4. Try to go as low as a 90 degree angle in your squat position (your legs create a 90 degree 
angle) 
5. Flat back  
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Day 1 EXERCISE #2 – LUNGES 
 
STEP 1 – Do 10 lunges on each leg. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Do another 10 lunges on each leg   










1. Make sure both toes pointed forward throughout the entire lunge  
2. Make a 90 degree angle with both legs – don’t step too far forward or not far enough  
3. Drive through your heel and thigh muscle to bring yourself back up from the lunge  
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Day 1 EXERCISE #3 – SINGLE LEG SQUAT  
 
STEP 1 – Do 10 single leg squats on each leg. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 single leg squats on each leg.  












1. Stick out your butt, as if you were sitting in a chair  
2. Make sure your knees DO NOT pass your toes.  
- If they do, try sticking your butt out more (so you aren’t leaning too far forward) 
or do not go as low into your squat position  
3. The goal is to be able to create a 90 degree angle similar to the squat  
- However it is challenging for single leg squats  
- Only go as low as you can go before your knees pass your toes  
4. Balance is important – use a chair or a wall to make sure the only part that is moving is 
your leg 
5. Flat back 
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 1 exercise two times then you are done.  
Great Job! 
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DAY 2: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 2 program twice through. You will be doing 
exercises that target your lower body.  
 
When you exercise, you want to exercise at an RPE intensity of 4-6  
 
 
**Remember to mark your workout on your workout calendar with a sticker, 
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DAY 2 – WARM UP & STRETCH  
1. Go for a 10-minute brisk walk or 10-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 8 times. Rest for 1 minute. Then go up and 
down your stairs 8 times again.  
OR: 
  
Alternate Warm Up 
- 50 jumping jacks  
- 20 high knees 
- 50 jumping jacks  
- 20 butt kicks 
- 50 jumping jacks  
- 20 high knees  





2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 2 EXERCISE #1 – SQUAT   
 
STEP 1 – Do 10 squats. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 squats  



























1. Feet shoulder width apart, or slightly wider than shoulder width apart  
2. Stick your butt out, and lower your body as if you were sitting in a chair  
3. Make sure your knees DO NOT pass your toes. 
- If they do, try sticking your butt out more (so you aren’t leaning too far forward) 
or do not go as low into your squat position  
4. Try to go as low as a 90 degree angle in your squat position (your legs create a 90 degree 
angle) 
5. Flat back  
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Day 2 EXERCISE #2 – SINGLE LEG CALF RAISES 
 
STEP 1 – Do 10 single leg calf raises on each leg. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 single leg calf raises on each leg 


























1. Use your toes and the ball of your foot to raise your heel off the ground  
2. Make sure toes are pointing forwards  
3. Balance is important – use a chair or a wall to make sure the only part that is moving is 
your leg  
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Day 2 EXERCISE #3  – WALL SIT 
 
STEP 1 – Do a wall sit for 20 seconds. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another wall sit for 20 seconds  



















1. Feet shoulder width apart  
2. Use the wall to brace your back, while using your thighs to hold you up  
3. Make a 90 degree angle with your legs 
4. Toes pointed forwards  
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 2 exercise two times then you are done.  
 
Great Job! 




DAY 3: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 3 program twice through. You will be doing 
exercises that target your lower body.  
 
When you exercise, you want to exercise at an RPE intensity of 4-6  
 
 
**Remember to mark your workout on your workout calendar with a sticker, 






























DAY 3 – WARM UP & STRETCH  
1. Go for a 10-minute brisk walk or 10-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 8 times. Rest for 1 minute. Then go up and 
down your stairs 8 times again.  
OR: 
  
Alternate Warm Up 
- 50 jumping jacks  
- 20 high knees 
- 50 jumping jacks 
- 20 butt kicks 
- 50 jumping jacks  
- 20 high knees 




2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 3 EXERCISE #1 – MOUNTAIN CLIMBERS   
STEP 1 – Do 10 mountain climbers on each leg. RPE = 4-6. 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 mountain climbers on each leg.  







1. Get into a “plank” position  
- Hands should be in line with shoulders  
- Flat back – squeeze your core (no butts in the air!) 
2. Drive your left leg (left knee) towards your left elbow – they don’t have to touch. Then 
switch legs  
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Day 3 EXERCISE #2 – STAIR STEP UPS 
STEP 1 – Do 10 stair step ups on each leg. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 stair step ups on each leg.  




























1. Toes pointed forwards  
2. Drive one leg up so your lifted leg is in a 90 degree angle position 
3. Use your arms for balance, and to help drive your leg up  
4. Stand tall – no slouching. Look straight ahead when stepping  
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Day 3 EXERCISE #3 – BURPEES  
STEP 1 – Do 10 burpees. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 burpees  















1. Jump as high as you can – both at the beginning and end of the burpee  
2. When you come down from your jump, get into a “plank” position  
- Hands in line with shoulders  
- Flat back – squeeze your core (no butts in the air!) 
3.  Modification – if you are unable to “jump back” into the plank position as showed in the video, 
get into the plank by stepping back one foot at a time. Still ensuring that once you are in the 
plank to have the proper form as listed above 
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 3 exercise two times then you are done.  
Great Job! 
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PHASE 2: 4 weeks, 3 times per week, 30-40 minute workouts 
 
What is the Rating of Perceived Exertion (RPE) Scale? 
- The RPE scale is used to measure the intensity of your exercise. The RPE scale 
scores how hard something feels to you from 0 – 10. 
- “0” is no exertion / difficulty 
- “10” is maximal effort / difficulty  
- The RPE scale below provides phrases used to rate how easy or difficult you 
find an activity.  
 
 
**Please ensure you or your child records the 
RPE value for each exercise day** 
 
 
How do I make an exercise feel harder?  
(if your RPE is less than 4 – you need to make your RPE between 4 and 6!) 
 
- Try doing the exercise slower 
o Count one-Mississippi, two-Mississippi, 3- Mississippi as you do your 
exercise (such as your squat)  
- Do extra reps  
o Do 12-15 reps instead of 10 
- If the exercise is timed, do the exercise for longer 
o Do 30 seconds instead of 20 seconds 
o walk for 15 minutes instead of 10 minutes 
- Reduce the amount of time of rest in between exercises!  
o Instead of 30 seconds, only wait 15 seconds to begin the exercise again.  
o Or, instead of 2 minutes, only wait 1 minute to begin the exercise again.  
 
 
To view entire CHAMPS 12 week program exercises, follow this link: 
https://drive.google.com/open?id=1eSUVcjXiJuoDLyYccohMWWu15H4AkVSo 
 
Be sure to review your exercise cues for each exercise! These are important so you don’t 
get hurt.  
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DAY 1: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 1 program twice through. You will be doing 
exercises that target your lower body.  
 




**Remember to mark your workout on your workout calendar with a sticker, 
and record how hard you were working (RPE=____)** 
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DAY 1 – WARM UP & STRETCH  
 
1. Go for a 15-minute brisk walk or 10-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 10 times. Rest for 1 minute. Then go up and 
down your stairs 10 times again.  
OR: 
  
Alternate Warm Up 
1. 50 jumping jacks  
2. 20 high knees 
3. 50 jumping jacks  
4. 20 butt kicks 
5. 50 jumping jacks  
6. 20 high knees  





2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 1 EXERCISE #1 – SQUAT AND HOLD 
 
STEP 1 – Do 10 squats.  
àHold the squat for 3 seconds before standing up and starting the next squat. 
OR: add weight to your squat. See video link for instructions.  
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 squats.  






















1. Feet shoulder width apart, or slightly wider than shoulder width apart  
2. Stick your butt out, and lower your body as if you were sitting in a chair  
3. Make sure your knees DO NOT pass your toes.  
- If they do, try sticking your butt out more (so you aren’t leaning too far forward) 
or do not go as low into your squat position  
4. Try to go as low as a 90 degree angle in your squat position (your legs create a 90 degree 
angle) 
5. Flat back  
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Day 1 EXERCISE #2 – BURPEES  
 
STEP 1 – Do 10 burpees. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 burpees  
STEP 4 – Rest for 1 minute. Then move on to Day 1 Exercise 3.  
 https://drive.google.com/open?id=1K0scGuD0kOYYu5PhCsXXaL8LJ1Cdip7R 
Cues: 
1. Jump as high as you can – both at the beginning and end of the burpee  
2. When you come down from your jump, get into a “plank” position  
- Hands in line with shoulders  
- Flat back – squeeze your core (no butts in the air!) 
3.  Modification – if you are unable to “jump back” into the plank position as showed in the 
video, get into the plank by stepping back one foot at a time. Still ensuring that once you 
are in the plank to have the proper form as listed above 
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Day 1 EXERCISE #3 – LUNGES 
 
STEP 1 – Do 10 lunges on each leg. RPE = 4-6 
à To make this exercise harder, you can add weight similar to how you did with 
the squats.  
STEP 2 – Rest for 15 seconds 
STEP 3 – Do another 10 lunges on each leg   





1. Make sure both toes pointed forward throughout the entire lunge  
2. Make a 90 degree angle with both legs – don’t step too far forward or not far enough  
3. Drive through your heel and thigh muscle to bring yourself back up from the lunge  
4. Flat back  
 
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 1 exercise two times then you are done.  
Great Job! 
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DAY 2: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 2 program twice through. You will be doing 
exercises that target your lower body.  
 
When you exercise, you want to exercise at an RPE intensity of 4-6  
 
 
**Remember to mark your workout on your workout calendar with a sticker, 
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DAY 2 – WARM UP & STRETCH  
 
1. Go for a 15-minute brisk walk or 10-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 10 times. Rest for 1 minute. Then go up and 
down your stairs 10 times again.  
OR: 
  
Alternate Warm Up 
- 50 jumping jacks  
- 20 high knees 
- 50 jumping jacks  
- 20 butt kicks 
- 50 jumping jacks  
- 20 high knees  




2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 2 EXERCISE #1  – WALL SIT 
 
STEP 1 – Do a wall sit for 30 seconds. RPE = 4-6 
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another wall sit for 30 seconds  








1. Feet shoulder width apart  
2. Use the wall to brace your back, while using your thighs to hold you up  
3. Make a 90 degree angle with your legs 
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Day 2 EXERCISE #2 – TUCK JUMP 
 
STEP 1 – Do 10 tuck jumps. RPE = 4-6 
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 tuck jumps. 























1. Bring knees as close to your chest as possible  
2. Jump as high as you can  
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Day 2 EXERCISE #3 – SINGLE LEG SQUAT 
 
STEP 1 – Do 10 single leg squats on each leg. RPE = 4-6 
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 single leg squats on each leg.  












1. Stick out your butt, and sit back into the chair   
2. Make sure your knee DOES NOT pass your toes.  
- If they do, try sticking your butt out more (so you aren’t leaning too far forward) 
or do not go as low into your squat position  
3. Sit lightly onto the chair, do not completely sit down when you squat  
4. Drive back up to a standing position using your single leg, ensuring you are standing up 
straight at the end 
5. Flat back 
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 2 exercise two times then you are done.  
Great Job! 
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DAY 3: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 3 program twice through. You will be doing 
exercises that target your lower body.  
 
When you exercise, you want to exercise at an RPE intensity of 4-6  
 
 
**Remember to mark your workout on your workout calendar with a sticker, 
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DAY 1 – WARM UP & STRETCH  
 
1. Go for a 15-minute brisk walk or 10-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 10 times. Rest for 1 minute. Then go up and 
down your stairs 10 times again.  
OR: 
  
Alternate Warm Up 
- 50 jumping jacks  
- 20 high knees 
- 50 jumping jacks  
- 20 butt kicks 
- 50 jumping jacks  
- 20 high knees  




2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 3 EXERCISE #1 – MOUNTAIN CLIMBERS   
STEP 1 – Do 15 mountain climbers on each leg. RPE = 4-6. 
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 mountain climbers on each leg.  







1. Get into a “plank” position  
- Hands should be in line with shoulders  
- Flat back – squeeze your core (no butts in the air!) 
2. Drive your left leg (left knee) towards your left elbow – they don’t have to touch. Then 
switch legs  
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Day 3 EXERCISE #2 – SINGLE LEG CALF RAISES w/hold  
 
STEP 1 – Do 10 single leg calf raises on each leg. RPE = 4-6 
à Hold for 2-3 seconds before coming back down and beginning next calf raise.  
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 single leg calf raises on each leg 

























1. Use your toes and the ball of your foot to raise your heel off the ground  
2. Make sure toes are pointing forwards  
3. Balance is important – use a chair or a wall to make sure the only part that is moving is 
your leg  
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Day 3 EXERCISE #3 – JUMP SQUATS 
 
STEP 1 – Do 10 jump squats. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 jump squats.  









1. Make sure you are completing the proper squat technique  
2. Jump as high as you can from your squat position  
3. When you land, make sure you return to a full squat position, then immediately jump 
back up to complete another squat jump 
 
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 3 exercise two times then you are done.  
 
Great Job! 
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PHASE 3 STARTS MARCH 24: 4 weeks, 3 times/week, 30-40 min  
 
à Please note the changes (longer duration or repeat more times) in the program 
for warm up and exercise sessions.  
 
What is the Rating of Perceived Exertion (RPE) Scale? 
- The RPE scale is used to measure the intensity of your exercise. The RPE scale 
scores how hard something feels to you from 0 – 10. 
- “0” is no exertion / difficulty 
- “10” is maximal effort / difficulty  
- The RPE scale below provides phrases used to rate how easy or difficult you 
find an activity.  
 
 
**Please ensure you or your child records the 
RPE value for each exercise day** 
 
 
How do I make an exercise feel harder?  
(if your RPE is less than 4 – you need to make your RPE between 4 and 6!) 
 
- Try doing the exercise slower 
o Count one-Mississippi, two-Mississippi, 3- Mississippi as you do your 
exercise (such as your squat)  
- Do extra reps  
o Do 12-15 reps instead of 10 
- If the exercise is timed, do the exercise for longer 
o Do 30 seconds instead of 20 seconds 
o walk for 15 minutes instead of 10 minutes 
- Reduce the amount of time of rest in between exercises!  
o Instead of 30 seconds, only wait 15 seconds to begin the exercise again.  
o Or, instead of 2 minutes, only wait 1 minute to begin the exercise again.  
 
To view entire CHAMPS 12 week program exercises, follow this link: 
https://drive.google.com/open?id=1eSUVcjXiJuoDLyYccohMWWu15H4AkVSo 
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DAY 1: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 1 program twice through. You will be doing 
exercises that target your lower body.  
 




**Remember to mark your workout on your workout calendar with a sticker, 
and record how hard you were working (RPE=____)** 
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DAY 1 – WARM UP & STRETCH  
 
1. Go for a 20-minute brisk walk or 15-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 15 times. Rest for 1 minute. Then go up and 
down your stairs 15 times again.  
 OR: 
 
 Alternate Warm Up 
- 50 jumping jacks  
- 20 high knees 
- 50 jumping jacks  
- 20 butt kicks 
- 50 jumping jacks  
- 20 high knees  




2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 1 EXERCISE #1 – PULSE SQUATS 
 
STEP 1 – Do 10 pulse squats.  
àDo a squat, come back up only halfway, go back down into the squat, come 
back up. Repeat.   
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 squats.  























1. Feet shoulder width apart, or slightly wider than shoulder width apart  
2. Stick your butt out, and lower your body as if you were sitting in a chair  
3. Make sure your knees DO NOT pass your toes.  
- If they do, try sticking your butt out more (so you aren’t leaning too far forward) 
or do not go as low into your squat position  
4. Try to go as low as a 90 degree angle in your squat position (your legs create a 90 degree 
angle) 
5. Flat back  
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Day 1 EXERCISE #2 – SUPERHERO TAKEOFFS 
 
STEP 1 – Do 5 lunge takeoffs on each leg. RPE = 4-6 
à Try the modified version first. Watch the videos closely for cues.  
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 5 lunge takeoffs on each leg.   








1. Ensure you are in a proper lunge position (legs at 90 degrees).  
2. Use your front leg to push off the ground and lift your back leg up in front of you. Try to 
end with your knee in a 90 degree angle (similar to step-up exercise position). 
3. Use your arms to help drive your leg up – try to make your movement controlled, but as 
explosive and powerful as you can.  
4. Try to complete each repetition with as little time in between as possible. Don’t take 
long breaks until you have completed all 5 on each leg.  
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Day 1 EXERCISE #3 – SINGLE LEG CALF RAISES w/hold 
 
STEP 1 – Do 15 single leg calf raises on each leg. RPE = 4-6 
à Hold for 2-3 seconds before coming back down and beginning next calf raise.  
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 15 single leg calf raises on each leg 





















1. Use your toes and the ball of your foot to raise your heel off the ground  
2. Make sure toes are pointing forwards  
3. Balance is important – use a chair or a wall to make sure the only part that is moving is 
your leg  
4. Stand tall – be sure to be looking straight ahead, no slouching  
 
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 1 exercise two times then you are done.  
Great Job! 
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DAY 2: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 2 program twice through. You will be doing 
exercises that target your lower body.  
 
When you exercise, you want to exercise at an RPE intensity of 4-6  
 
 
**Remember to mark your workout on your workout calendar with a sticker, 
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DAY 2 – WARM UP & STRETCH  
 
1. Go for a 20-minute brisk walk or 15-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 15 times. Rest for 1 minute. Then go up and 
down your stairs 15 times again.  
OR: 
 Alternate Warm Up 
- 50 jumping jacks  
- 20 high knees  
- 50 jumping jacks  
- 20 butt kicks 
- 50 jumping jacks  
- 20 high knees 




2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  









2019 CHAMPS – 12 week home based exercise study 
 
 133 
Day 2 EXERCISE #1  – FORWARD/BACKWARD LUNGES 
STEP 1 – Do 10 lunges on each leg. RPE = 4-6 
à To make this exercise harder add weight or hold the lunge for 2-3 seconds 
STEP 2 – Rest for 15 seconds 
STEP 3 – Do another 10 lunges on each leg   





















1. Make sure both toes pointed forward throughout the entire lunge  
2. Make a 90 degree angle with both legs – don’t step too far forward or not far enough  
3. Your knee should not go past your toes 
4. Drive through your heel and thigh muscle to bring yourself back up from the lunge  
5. Flat back  
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Day 2 EXERCISE #2 – JUMP SQUAT 
STEP 1 – Do 10 jump squats. RPE = 4-6 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 10 jump squats.  















1. Make sure you are completing the proper squat technique  
2. Jump as high as you can from your squat position  
3. When you land, make sure you return to a full squat position, then immediately jump 
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Day 2 EXERCISE #3 – WALL SIT  
 
STEP 1 – Do a wall sit for 45 seconds. RPE = 4-6 
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another wall sit for 45 seconds  







1. Feet shoulder width apart  
2. Use the wall to brace your back, while using your thighs to hold you up  
3. Make a 90 degree angle with your legs 




**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
Once you have done the Day 2 exercise two times then you are done.  
Great Job! 
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DAY 3: OVERVIEW 
 
WARM UP: Complete the warm up options listed below to get your body ready for 
exercise!  
 
STRETCH: Then find a space in your home to complete warm up stretches listed on 
next page.   
 
EXERCISE: Complete entire Day 3 program twice through. You will be doing 
exercises that target your lower body.  
 
When you exercise, you want to exercise at an RPE intensity of 4-6  
 
 
**Remember to mark your workout on your workout calendar with a sticker, 
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DAY 3 – WARM UP & STRETCH  
 
1. Go for a 20-minute brisk walk or 15-minute jog (RPE = 4-6). This should be 
how you would walk when you are in a rush to get somewhere. 
OR: 
Go up and down your stairs 15 times. Rest for 1 minute. Then go up and 
down your stairs 15 times again.  
 OR: 
 
 Alternate Warm Up 
- 50 jumping jacks  
- 20 high knees  
- 50 jumping jacks  
- 20 butt kicks 
- 50 jumping jacks  
- 20 high knees 




2. Complete the stretches below.  
- Hamstring Stretch – hold for 30 seconds each leg  
- Thigh Stretch – hold for 30 seconds each leg  
- Butterfly Stretch – hold for 30 seconds  
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Day 3 EXERCISE #1 – SPLIT SQUATS   
STEP 1 – Do 10 split squats on each leg (switching leg that is in front). RPE = 4-6. 
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 split squats on each leg.  









1. Both feet face forwards – go down into your normal lunge position  
2. Ensure your knee does not go past your toes  
3. Keeping your feet in place, come up from the lunge. Legs straighten. Then go back down 
into the lunge.  
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Day 3 EXERCISE #2 – BURPEES 
STEP 1 – Do 12 burpees. RPE = 4-6. 
STEP 2 – Rest for 30 seconds 
STEP 3 – Then do another 12 burpees.  
STEP 4 – Rest for 1 minute. Then move on to Day 3 Exercise 3.  
 https://drive.google.com/open?id=1db0il03aWgsHfS-Y_cKBg4YtkQVIcxMq 
Cues: 
1. Jump as high as you can – both at the beginning and end of the burpee  
2. When you come down from your jump, get into a “plank” position  
- Hands in line with shoulders  
- Flat back – squeeze your core (no butts in the air!) 
3.  Modification – if you are unable to “jump back” into the plank position as showed in the 
video, get into the plank by stepping back one foot at a time. Still ensuring that once you 
are in the plank to have the proper form as listed above 
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Day 3 EXERCISE #3 – SUMO SQUATS  
 
STEP 1 – Do 10 sumo squats. RPE = 4-6. 
STEP 2 – Rest for 15 seconds 
STEP 3 – Then do another 10 sumo squats.    














1. Feet slightly wider than shoulder width apart, feet pointed at a 45 degree angle 
2. Same as normal squat – sit back in a chair, flat back, knees do not go over toes  
3. Make sure knees do not “collapse inwards”. Try to keep them in line with your feet.  
 
**NOW REPEAT EXERCISES #1, #2, AND #3 ALL OVER AGAIN!  
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